Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension, January 2024 Free Subscription Abstracts Retrieve all available abstracts of the following 707 articles: HTML format

Single Articles

1. BADAGLIACCA R, Ghio S, Manzi G, Vizza CD, et al
   Right Ventricular/Pulmonary Artery Coupling in Patients With Heart Failure With Preserved Ejection Fraction: A Clue for Pulmonary Hypertension?
   J Am Heart Assoc. 2023 Dec 29:e032639. doi: 10.1161/JAHA.123.032639.
   Abstract     Related articles   
   
   
2. CHEN ZW, Chung YW, Cheng JF, Huang CY, et al
   Right Ventricular-Vascular Uncoupling Predicts Pulmonary Hypertension in Clinically Diagnosed Heart Failure With Preserved Ejection Fraction.
   J Am Heart Assoc. 2023 Dec 29:e030025. doi: 10.1161/JAHA.123.030025.
   Abstract     Related articles   
   
   
3. HE Z, Zhang D, Wang X
   Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting.
   Eur Heart J. 2023 Dec 28:ehad862. doi: 10.1093.
   Abstract     Related articles   
   
   
4. KLEINNIBBELINK G, Buckley BJR, Harrison SL, Williams N, et al
   Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension.
   Front Sports Act Living. 2023;5:1247615.
   Abstract     Related articles   
   
   
5. WILLIAMS EE, Bednarczuk N, Nanjundappa M, Greenough A, et al
   Monitoring persistent pulmonary hypertension of the newborn using the arterial to end tidal carbon dioxide gradient.
   J Clin Monit Comput. 2023 Dec 27. doi: 10.1007/s10877-023-01105.
   Abstract     Related articles   
   
   
6. STUBBS H, Lua S, Ingram J, Jani BD, et al
   Remote exercise testing in pulmonary hypertension (PHRET).
   Pulm Circ. 2023;13:e12325.
   Abstract     Related articles   
   
   
7. KAVGACI A, Tunaoglu FS, Kula S, Oguz AD, et al
   Early Echocardiographic Findings of Pulmonary Hypertension-specific Therapy in Children.
   Medeni Med J. 2023;38:268-275.
   Abstract     Related articles   
   
   
8. LAN C, Fang G, Qiu C, Li X, et al
   Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
   Clin Exp Hypertens. 2024;46:2297642.
   Abstract     Related articles   
   
   
9. LONE AM, Kanthimathinathan HK
   Milrinone in pediatric heart failure and pulmonary hypertension: Is meta-analyses the answer?
   Eur J Pediatr. 2023 Dec 26. doi: 10.1007/s00431-023-05402.
   Abstract     Related articles   
   
   
10. HAFNER F, Johansson C, Schwarzkopf L, Forster K, et al
    Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia-A survey study in Germany (PUsH BPD).
    Pulm Circ. 2023;13:e12320.
    Abstract     Related articles   
    
    
11. MORLAND K, Gerges C, Elwing J, Visovatti SH, et al
    Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Grou
    Pulm Circ. 2023;13:e12317.
    Abstract     Related articles   
    
    
12. SYNN AJ, Harder EM, Nardelli P, Ross JC, et al
    Automated CT-Based Quantification of Pulmonary Veins Shows Greater Central Venous Dilation in Group 2 Pulmonary Hypertension Compared With Group 1 Pulmonary Arterial Hypertension and Control Subjects.
    CHEST Pulm. 2023;1:100020.
    Abstract     Related articles   
    
    
13. SUZUKI Y, Nagaoka T, Terayama Y, Nagata Y, et al
    Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.
    Respir Investig. 2023;62:167-175.
    Abstract     Related articles   
    
    
14. YEGAMBARAM M, Sun X, Flores AG, Lu Q, et al
    Novel Relationship between Mitofusin 2-Mediated Mitochondrial Hyperfusion, Metabolic Remodeling, and Glycolysis in Pulmonary Arterial Endothelial Cells.
    Int J Mol Sci. 2023;24:17533.
    Abstract     Related articles   
    
    
15. PAPAVASSILIOU KA, Gogou VA, Papavassiliou AG
    Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
    Int J Mol Sci. 2023;24:17441.
    Abstract     Related articles   
    
    
16. TOPYLA-PUTOWSKA W, Tomaszewski M, Wojtkowska A, Wysokinski A, et al
    Novel Echocardiographic Measurements of Right Ventricular-Pulmonary Artery Coupling in Predicting the Prognosis of Precapillary Pulmonary Hypertension.
    J Pers Med. 2023;13:1627.
    Abstract     Related articles   
    
    
17. PILKA M, Darocha S, Florczyk M, Manczak R, et al
    The Utility of a Resting Electrocardiogram (ECG-PH Index) in Evaluating the Efficacy of Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
    J Clin Med. 2023;12:7621.
    Abstract     Related articles   
    
    
18. KUROPATKINA T, Atiakshin D, Sychev F, Artemieva M, et al
    Hydrogen Inhalation Reduces Lung Inflammation and Blood Pressure in the Experimental Model of Pulmonary Hypertension in Rats.
    Biomedicines. 2023;11:3141.
    Abstract     Related articles   
    
    
19. YAN S, Sheak JR, Walker BR, Jernigan NL, et al
    Contribution of Mitochondrial Reactive Oxygen Species to Chronic Hypoxia-Induced Pulmonary Hypertension.
    Antioxidants (Basel). 2023;12:2060.
    Abstract     Related articles   
    
    
20. LUN X, Yang J, Liu Y, Zhao F, et al
    Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Medicine (Baltimore). 2023;102:e36654.
    Abstract     Related articles   
    
    
21. ELKHAPERY A, Hammami MB, Sulica R, Boppana H, et al
    Pulmonary Vasodilator Therapy in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (Severe PH-COPD): A Systematic Review and Meta-Analysis.
    J Cardiovasc Dev Dis. 2023;10:498.
    Abstract     Related articles   
    
    
22. HOPKINS CD, Wessel C, Chen O, El-Kersh K, et al
    A hypothesis: Potential contributions of metals to the pathogenesis of pulmonary artery hypertension.
    Life Sci. 2024;336:122289.
    Abstract     Related articles   
    
    
23. XIONG J, Peng Y, Li J, Cai S, et al
    Total iron binding capacity: an independent predictor of prognosis for pulmonary arterial hypertension in systemic lupus erythematosus.
    Scand J Rheumatol. 2024;53:44-48.
    Abstract     Related articles   
    
    
24. NANDI D, Kumar S, Singh R
    Does Bronchial Artery Hypertrophies After Descending Thoracic Aorta Stenting in Takayasu Arteritis? - A Clinical Dilemma.
    Vasc Endovascular Surg. 2024;58:218-222.
    Abstract     Related articles   
    
    
25. 
    Pulmonary hypertension.
    Nat Rev Dis Primers. 2024;10:2.
    Abstract     Related articles   
    
    
26. MOCUMBI A, Humbert M, Saxena A, Jing ZC, et al
    Pulmonary hypertension.
    Nat Rev Dis Primers. 2024;10:1.
    Abstract     Related articles   
    
    
27. DONG R, Liang Y, Ni M, Wang D, et al
    Electrocardiogram Parameters Associated With the Diagnosis of Pulmonary Hypertension in High-Altitude Tibetan Populations: A Retrospective Single-Centre Study.
    Heart Lung Circ. 2024 Jan 3:S1443-9506(23)04418.
    Abstract     Related articles   
    
    
28. TANG C, Shi F, Ji Y, Zhu J, et al
    Aldehyde Dehydrogenase 2 (ALDH2) rs671 Polymorphism is a Predictor of Pulmonary Hypertension Due to Left Heart Disease.
    Heart Lung Circ. 2024 Jan 4:S1443-9506(23)04446.
    Abstract     Related articles   
    
    
29. KIELY DG, Hamilton N, Wood S, Durrington C, et al
    Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service.
    BMJ Open. 2024;14:e080068.
    Abstract     Related articles   
    
    
30. LIU M, Wang X, Yan Z, Wang Z, et al
    Network Analysis on Family Resilience, Fear of Progression, and Quality of Life in Chinese Patients with Pulmonary Hypertension.
    Heart Lung. 2024;64:128-136.
    Abstract     Related articles   
    
    
31. HUANG YZ, Wu JC, Lu GF, Li HB, et al
    Pulmonary Hypertension Induces Serotonin Hyperreactivity and Metabolic Reprogramming in Coronary Arteries via NOX1/4-TRPM2 Signaling Pathway.
    Hypertension. 2024 Jan 4. doi: 10.1161/HYPERTENSIONAHA.123.21345.
    Abstract     Related articles   
    
    
32. NATHAN SD, Tehrani B, Zhao Q, Arias R, et al
    Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis.
    Pulm Circ. 2024;14:e12311.
    Abstract     Related articles   
    
    
33. SATAWIRIYA M, Khongphatthanayothin A, Limsuwan A
    Reversible severe pulmonary hypertension related to scurvy in children.
    BMC Cardiovasc Disord. 2024;24:24.
    Abstract     Related articles   
    
    
34. WAN JJ, Yi J, Wang FY, Zhang C, et al
    Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment.
    Int J Med Sci. 2024;21:45-60.
    Abstract     Related articles   
    
    
35. WANG J, Liu J, Tao X, Xie W, et al
    Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2023;14:e12327.
    Abstract     Related articles   
    
    
36. YE T, Song Z, Zhou Y, Liu Z, et al
    TRPV2 inhibitor tranilast prevents atrial fibrillation in rat models of pulmonary hypertension.
    Cell Calcium. 2023;117:102840.
    Abstract     Related articles   
    
    
37. UMETANI K, Atsumi M
    Haemodialysis patient with chronic kidney disease and pulmonary hypertension treated effectively with pulmonary vasodilators.
    BMJ Case Rep. 2023;16:e255810.
    Abstract     Related articles   
    
    
38. TALWAR S, Gangoor N, Maldar SB, Pinto CJ, et al
    Isolated unilateral pulmonary artery atresia in an adult presenting with cor pulmonale.
    BMJ Case Rep. 2023;16:e256663.
    Abstract     Related articles   
    
    
39. SHARIYA AM, Martynyuk TV, Shariya MA, Ustyuzhanin DV, et al
    [Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension].
    Ter Arkh. 2023;95:291-295.
    Abstract     Related articles   
    
    
40. CHAZOVA IE
    [Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review].
    Ter Arkh. 2023;95:1017-1021.
    Abstract     Related articles   
    
    
41. GAO AL, Gong JN, Li JF, Yang YH, et al
    [A case of heritable pulmonary arterial hypertension treated with long-term oral low-dose imatinib].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:36-38.
    Abstract     Related articles   
    
    
42. TRAMMELL AW, Hart CM
    LKB1 Regulates Pulmonary Hypertension Endothelial Cell Mitochondria: Another Layer of the Pulmonary Vascular Onion?
    Am J Respir Cell Mol Biol. 2024;70:5-7.
    Abstract     Related articles   
    
    
43. CALLISTO A, Hansen D, Walker J, Ngian GS, et al
    Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis.
    Arthritis Care Res (Hoboken). 2024;76:81-87.
    Abstract     Related articles   
    
    
44. LENTINE KL, Levine DJ, Runo JR, Caliskan Y, et al
    Complexities and outcomes of pulmonary hypertension in kidney transplant patients: a comprehensive review.
    Turkish J Nephrol. 2024;33:8-26.
    Abstract     Related articles   
    
    
45. IVANOV B, Krasivskyi I, Forster F, Gaisendrees C, et al
    Impact of pulmonary hypertension on short-term outcomes in patients undergoing surgical aortic valve replacement for severe aortic valve stenosis.
    Perfusion. 2024 Jan 11:2676591241227883. doi: 10.1177/02676591241227883.
    Abstract     Related articles   
    
    
46. OUELLET S, Drolet C, Morissette G, Pellerin A, et al
    Vasopressin in newborns with refractory acute pulmonary hypertension.
    Pediatr Res. 2024 Jan 11. doi: 10.1038/s41390-023-02995.
    Abstract     Related articles   
    
    
47. YANG Y, Li X, Wang P, Shu S, et al
    The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.
    Ther Adv Respir Dis. 2024;18:17534666231224692.
    Abstract     Related articles   
    
    
48. SINGHI AK, Mohapatra SK, Biswas N, Bandyopadhyay KH, et al
    PULMOEAST: A Comprehensive Analysis of Pulmonary Hypertension in Eastern India.
    Cureus. 2023;15:e50996.
    Abstract     Related articles   
    
    
49. SHLOBIN OA, Shen E, Wort SJ, Piccari L, et al
    Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.
    Pulm Circ. 2024;14:e12310.
    Abstract     Related articles   
    
    
50. DESAI R, Gandhi Z, Shiza ST, Jain A, et al
    Prevalence and impact of tobacco use disorder on in-hospital mortality in patients hospitalized with non-group 1 pulmonary hypertension: a nationwide propensity score-matched analysis, 2019.
    EXCLI J. 2023;22:1200-1210.
    Abstract     Related articles   
    
    
51. D'AGOSTINO A, Lanzafame LG, Buono L, Crisci G, et al
    Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2023;25:36.
    Abstract     Related articles   
    
    
52. CONTRERAS J, Nussbaum J, Cangialosi P, Thapi S, et al
    Pulmonary Hypertension in Underrepresented Minorities: A Narrative Review.
    J Clin Med. 2024;13:285.
    Abstract     Related articles   
    
    
53. MATOS JI, Garcia-Rodriguez SN, Costa-Rodriguez N, Caro-Vadillo A, et al
    Right Ventricle Strain Assessed by 2-Dimensional Speckle Tracking Echocardiography (2D-STE) to Evaluate Pulmonary Hypertension in Dogs with Dirofilaria immitis.
    Animals (Basel). 2023;14:26.
    Abstract     Related articles   
    
    
54. ZHANG A, Ding L, Zhang H, Mi L, et al
    Radiofrequency catheter ablation for pulmonary hypertension patients with atrial flutter.
    ESC Heart Fail. 2024 Jan 10. doi: 10.1002/ehf2.14659.
    Abstract     Related articles   
    
    
55. YU X, Qin W, Cai H, Ren C, et al
    Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking.
    Comput Biol Med. 2023;169:107863.
    Abstract     Related articles   
    
    
56. TAI YY, Yu Q, Tang Y, Sun W, et al
    Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension.
    Sci Transl Med. 2024;16:eadd2029.
    Abstract     Related articles   
    
    
57. ZHANG J, Xu C, Tang X, Sun S, et al
    Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through KLF4 deacetylation.
    Cardiovasc Res. 2024 Jan 10:cvae011. doi: 10.1093.
    Abstract     Related articles   
    
    
58. RAJKUMAR S, Jha AK, Parida S, Thangaswamy CR, et al
    Effect of Acute Vasodilator Testing Using Oxygen in Pulmonary Hypertension Due to Left Heart Disease.
    Semin Cardiothorac Vasc Anesth. 2024 Jan 10:10892532241227082.
    Abstract     Related articles   
    
    
59. HUANG J, Zhang W, Fu W, Le J, et al
    Noninvasive evaluation of pulmonary hypertension using the second heart sound parameters collected by a mobile cardiac acoustic monitoring system.
    Front Cardiovasc Med. 2023;10:1292647.
    Abstract     Related articles   
    
    
60. ALVAREZ TRONCOSO J, Soto Abanades C, Robles-Marhuenda A, Alcolea Batres S, et al
    Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol.
    RMD Open. 2024;10:e003674.
    Abstract     Related articles   
    
    
61. BRITO J, Pinto FJ, Placido R
    Chronic fibrothrombotic deposits: a cause or consequence of pulmonary hypertension?
    Rev Esp Cardiol (Engl Ed). 2024 Jan 6:S1885-5857(24)00015.
    Abstract     Related articles   
    
    
62. SCHULZE KM, Horn AG, Weber RE, Behnke BJ, et al
    Pulmonary hypertension alters blood flow distribution and impairs the hyperemic response in the rat diaphragm.
    Front Physiol. 2023;14:1281715.
    Abstract     Related articles   
    
    
63. ABDEEN AMZ, Alagha Z, Clark C, Al-Astal A, et al
    Paradoxical Worsening of Pulmonary Hypertension Following Closure of Arteriovenous Fistula: A Case Report and Literature Review.
    Cureus. 2023;15:e50064.
    Abstract     Related articles   
    
    
64. SONAGLIONI A, Nicolosi GL, Rispoli GA, Lombardo M, et al
    Incidental Finding of Lipomatous Hypertrophy of the Right Atrial Free Wall in an Elderly Female With Severe Pulmonary Hypertension: Early Detection by Multimodality Imaging.
    Cureus. 2023;15:e50665.
    Abstract     Related articles   
    
    
65. ZHENG SW, Wang Z, Zhai ZG, Sun YH, et al
    [Progresses in pulmonary hypertension associated with left-sided heart failure].
    Zhonghua Nei Ke Za Zhi. 2024;63:113-120.
    Abstract     Related articles   
    
    
66. ULRICH A, Wu Y, Draisma H, Wharton J, et al
    Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.
    Nat Commun. 2024;15:330.
    Abstract     Related articles   
    
    
67. SALAZAR AM, Panama G, Kim AG, Rayamajhi S, et al
    Clinical outcomes between direct oral anticoagulants versus vitamin K antagonists in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Curr Probl Cardiol. 2024;49:102377.
    Abstract     Related articles   
    
    
68. TOMITA S, Nakanishi N, Ogata T, Higuchi Y, et al
    The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.
    Commun Biol. 2024;7:40.
    Abstract     Related articles   
    
    
69. GUPTA S, Mohta A, Thameem D
    Vasoreactive pulmonary artery hypertension in non-fibrotic hypersensitive pneumonitis.
    BMJ Case Rep. 2024;17:e255921.
    Abstract     Related articles   
    
    
70. DONG S, Guo X, Wang H, Sun C, et al
    Liver injury due to endothelin receptor antagonists: a real-world study based on post-marketing drug monitoring data.
    Ther Adv Respir Dis. 2024;18:17534666231223606.
    Abstract     Related articles   
    
    
71. DE BIE FR, Regin Y, Dubois A, Scuglia M, et al
    Prenatal treprostinil improves pulmonary arteriolar hypermuscularization in the rabbit model of congenital diaphragmatic hernia.
    Biomed Pharmacother. 2024;170:115996.
    Abstract     Related articles   
    
    
72. AKSOY A, Kocakaya D, Demircioglu O, Cimsit NC, et al
    Angiographic findings of pulmonary arterial involvement in Behcet's Disease: Do they correlate with symptoms and acute phase response?
    Respir Med. 2024;221:107481.
    Abstract     Related articles   
    
    
73. CHE Y, Xia T, Liu H, Li C, et al
    Preparation of betaine injection and its therapeutic effect in pulmonary arterial hypertension.
    Basic Clin Pharmacol Toxicol. 2024;134:219-230.
    Abstract     Related articles   
    
    
74. HUANG Z, Duan A, Zhao Z, Zhao Q, et al
    Sleep-disordered breathing patterns and prognosis in pulmonary arterial hypertension: A cluster analysis of nocturnal cardiorespiratory signals.
    Sleep Med. 2024;113:61-69.
    Abstract     Related articles   
    
    
75. SZABARI MV, Ni C, Davila D, Viragh K, et al
    Pulmonary Arterial Tumor Embolism From Recurrent Metastatic Renal Cell Carcinoma on FDG PET/CT.
    Clin Nucl Med. 2023 Nov 17. doi: 10.1097/RLU.0000000000004956.
    Abstract     Related articles   
    
    
76. SALAHUDDIN M, Shahid S, Tariq U, Aqeel M, et al
    Outcomes of patients with elevated pulmonary artery systolic pressure on echocardiography due to chronic lung diseases.
    Respir Investig. 2024;62:69-74.
    Abstract     Related articles   
    
    
77. KULARATNE M, Boucly A, Savale L, Solinas S, et al
    Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
    Expert Opin Pharmacother. 2023;24:2101-2115.
    Abstract     Related articles   
    
    
78. MANSOOR M, Shahid S, Tariq S, Aziz A, et al
    Letter to Editor: Prevalence and Determinants of Delay in Time-to-Diagnosis for Pulmonary Arterial Hypertension (PAH) Patients in Gansu China: An Observational Cohort Study.
    Curr Probl Cardiol. 2024;49:102133.
    Abstract     Related articles   
    
    
79. BZDEGA K, Biela M, Deutsch GH, Kitzmiller JA, et al
    A novel non-recurrent CNV deletion involving TBX4 and leaving TBX2 intact causes congenital alveolar dysplasia.
    Clin Genet. 2024;105:190-195.
    Abstract     Related articles   
    
    
80. HUO X, Zeng Z, Lin Y, Lin J, et al
    Clinical characteristics of systemic sclerosis patients with occupational silicosis.
    Clin Rheumatol. 2024;43:277-287.
    Abstract     Related articles   
    
    
81. TOWER DR, Day RW, Marrone T, Palmquist R, et al
    Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure.
    Cold Spring Harb Mol Case Stud. 2024;9:a006292.
    Abstract     Related articles   
    
    
82. TOSHIMA T, Rhu J, Yoon YI, Ito T, et al
    Aborted living-donor liver transplantation in the real-world setting, lessons from 13 937 cases of Vanguard Multi-center Study of International Living Donor Liver Transplantation Group.
    Am J Transplant. 2024;24:57-69.
    Abstract     Related articles   
    
    
83. LAI Y, Chen M, Chen M, Li C, et al
    Gender differences in the incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A meta-analysis.
    Medicine (Baltimore). 2024;103:e35150.
    Abstract     Related articles   
    
    
84. SANTAMANS AM, Cicuendez B, Mora A, Villalba-Orero M, et al
    MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension.
    Sci Adv. 2024;10:eadk6524.
    Abstract     Related articles   
    
    
85. ZANOTTO TM, Goncalves AESS, Saad MJA
    Pulmonary hypertension and insulin resistance: a mechanistic overview.
    Front Endocrinol (Lausanne). 2024;14:1283233.
    Abstract     Related articles   
    
    
86. JIN J, Rothamel P, Buchel J, Kammer B, et al
    Case Report: Stuve-Wiedemann syndrome-a rare cause of persistent pulmonary hypertension of the newborn.
    Front Pediatr. 2024;11:1329404.
    Abstract     Related articles   
    
    
87. WARNER ED, Corsi DR, Jimenez D, Bierowski M, et al
    Determinants of Pulmonary Hypertension in Patients with End-stage Kidney Disease and Arteriovenous Access.
    Curr Probl Cardiol. 2024 Jan 16:102406. doi: 10.1016/j.cpcardiol.2024.102406.
    Abstract     Related articles   
    
    
88. YAGHOOBI N, Maghsudi M, Malek H, Bakhshandeh H, et al
    Role of CT attenuation correction gated SPECT MPI in prediction of pulmonary hypertension.
    J Nucl Cardiol. 2023;31:101777.
    Abstract     Related articles   
    
    
89. LI S, Lyu Q, Shi Q, Bai Y, et al
    Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-gamma axis.
    Clin Sci (Lond). 2024 Jan 18:CS20231508. doi: 10.1042/CS20231508.
    Abstract     Related articles   
    
    
90. KONG L, Lv M, Qiao CL, Sun XX, et al
    The effect of pituitrin on postoperative outcomes in patients with pulmonary hypertension undergoing cardiac surgery: a study protocol for a randomized controlled trial.
    Front Cardiovasc Med. 2024;10:1269624.
    Abstract     Related articles   
    
    
91. HUANG J, Zhu H, Liu S, Li M, et al
    Protein profiling in systemic sclerosis patients with different pulmonary complications using proteomic antibody microarray.
    Arthritis Res Ther. 2024;26:29.
    Abstract     Related articles   
    
    
92. MOCUMBI A, Humbert M, Saxena A, Jing ZC, et al
    Publisher Correction: Pulmonary hypertension.
    Nat Rev Dis Primers. 2024;10:5.
    Abstract     Related articles   
    
    
93. VAN HEERDEN JK, Louw EH, Thienemann F, Engel ME, et al
    The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis.
    Eur Respir Rev. 2024;33:230154.
    Abstract     Related articles   
    
    
94. LECHARTIER B, Boucly A, Solinas S, Gopalan D, et al
    Pulmonary veno-occlusive disease: illustrative cases and literature review.
    Eur Respir Rev. 2024;33:230156.
    Abstract     Related articles   
    
    
95. ZAROGOULIDIS P, Petridis D, Huang H, Bai C, et al
    Nebulisation of Paclitaxel, Sotatercept and Iloprost for pulmonary hypertension for lung cancer. From In vitro to In vivo.
    J Cancer. 2024;15:871-879.
    Abstract     Related articles   
    
    
96. YANG Y, Xu J, Shu S, Wang P, et al
    Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension.
    BMC Pulm Med. 2024;24:35.
    Abstract     Related articles   
    
    
97. HSIAO CY, Lu WH
    Effective control of refractory pulmonary hypertension with iloprost inhalation in an infant with congenital absence of the right pulmonary artery: a case report.
    Cardiol Young. 2024 Jan 15:1-4. doi: 10.1017/S104795112300450.
    Abstract     Related articles   
    
    
98. ZHANG Y, Zhang Y, Liao C, Wang X, et al
    Prognostic implication of glomerular filtration rates in patients with chronic thromboembolic pulmonary hypertension who have undergone balloon pulmonary angioplasty.
    Exp Ther Med. 2023;27:18.
    Abstract     Related articles   
    
    
99. FERNICOLA F, Carli A, Arienti F, Viola Vasarri M, et al
    Fatal severe persistent pulmonary hypertension with lung microvasculature parietal hyperplasia in a neonate with congenital cytomegalovirus infection treated in-utero with valacyclovir: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2024 Jan 11:S0301-2115(24)00011.
    Abstract     Related articles   
    
    
100. CHOI R, Narayanan R, Jandu S, Savage W, et al
     Optimization of resting tension for wire myography in male rat pulmonary arteries.
     Physiol Rep. 2024;12:e15911.
     Abstract     Related articles   
     
     
101. HUYNH T
     Commentary on studies investigating low-dose diazoxide in hyperinsulinism.
     Clin Endocrinol (Oxf). 2024;100:138-139.
     Abstract     Related articles   
     
     
102. WALIGORA M, Smorag M, Bukala N, Zygmunt M, et al
     ECG patterns to predict pulmonary arterial hypertension in patients with severe tricuspid regurgitation.
     J Electrocardiol. 2024;82:52-58.
     Abstract     Related articles   
     
     
103. LI M, Ying M, Gu S, Zhou Z, et al
     Matrine alleviates hypoxia-induced inflammation and pulmonary vascular remodelling via RPS5/NF-kappaB signalling pathway.
     J Biochem Mol Toxicol. 2024;38:e23583.
     Abstract     Related articles   
     
     
104. YAVUZ YE, Soylu A, Gurbuz AS
     The relationship of systemic and pulmonary arterial parameters with HFpEF scores (H(2) FPEF, HFA-PEFF) and diastolic dysfunction parameters in heart failure patients with preserved ejection fraction.
     J Clin Ultrasound. 2024;52:39-50.
     Abstract     Related articles   
     
     
105. MCLAUGHLIN V, Alsumali A, Liu R, Klok R, et al
     Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).
     Adv Ther. 2024;41:130-151.
     Abstract     Related articles   
     
     
106. PAMUKCU O, Narin N, Sunkak S, Tuncay A, et al
     Evaluation of preterm infants having bronchopulmonary dysplasia with echocardiography and serum biomarkers.
     Cardiol Young. 2024;34:137-144.
     Abstract     Related articles   
     
     
107. LI R, Song M, Wang R, Su N, et al
     Can CT-Based Arterial and Venous Morphological Markers of Chronic Obstructive Pulmonary Disease Explain Pulmonary Vascular Remodeling?
     Acad Radiol. 2024;31:22-34.
     Abstract     Related articles   
     
     
108. YUAN M, Hu X, Xing W, Wu X, et al
     B2M is a Biomarker Associated With Immune Infiltration In High Altitude Pulmonary Edema.
     Comb Chem High Throughput Screen. 2024;27:168-185.
     Abstract     Related articles   
     
     
109. PLOEGSTRA MJ, Ivy DD, Beghetti M, Bonnet D, et al
     Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry.
     Eur Heart J Qual Care Clin Outcomes. 2024;10:66-76.
     Abstract     Related articles   
     
     
110. RILEY JM, Fradin JJ, Russ DH, Warner ED, et al
     Post-Capillary Pulmonary Hypertension: Clinical Review.
     J Clin Med. 2024;13:625.
     Abstract     Related articles   
     
     
111. BAILEY M, DuBrock HM
     Pulmonary hypertension patient perspectives toward pulmonary rehabilitation.
     Pulm Circ. 2024;14:e12338.
     Abstract     Related articles   
     
     
112. ANAND V, Covington MK, Saraswati U, Scott CG, et al
     Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathy.
     Front Cardiovasc Med. 2024;10:1288747.
     Abstract     Related articles   
     
     
113. LEBAR K, Liu W, Pang J, Chicco A, et al
     Role of the Microtubule Network in the Passive Anisotropic Viscoelasticity of Right Ventricle with Pulmonary Hypertension Progression.
     Acta Biomater. 2024 Jan 23:S1742-7061(24)00035.
     Abstract     Related articles   
     
     
114. YOU YT, Zuo H, Li JM, Zhu XB, et al
     Mediastinal Cryobiopsy for Pathological Diagnosis of Fibrosing Mediastinitis-Associated Pulmonary Hypertension.
     Respiration. 2024 Jan 25:1-5. doi: 10.1159/000535395.
     Abstract     Related articles   
     
     
115. CARAVITA S, Gori M, Garascia A, Baratto C, et al
     [Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment].
     G Ital Cardiol (Rome). 2024;25:88-97.
     Abstract     Related articles   
     
     
116. SUN L, Liu L, Liang D, Liu L, et al
     SOCS5, targeted by miR-155-5p, plays a negative regulatory role in pulmonary hypertension through inhibiting JAK2/STAT3 signaling pathway.
     BMC Pulm Med. 2024;24:52.
     Abstract     Related articles   
     
     
117. CAO JK, Fan HQ, Xiao YB, Wang D, et al
     [Establishment and efficiency test of a clinical prediction model of bronchopulmonary dysplasia associated pulmonary hypertension in very premature infants].
     Zhonghua Er Ke Za Zhi. 2024;62:129-137.
     Abstract     Related articles   
     
     
118. MCCORMACK C, Kehoe B, Cullivan S, McCaffrey N, et al
     Safety, feasibility and effectiveness of the remotely delivered Pulmonary Hypertension and Home-Based (PHAHB) physical activity intervention.
     ERJ Open Res. 2024;10:00608-2023.
     Abstract     Related articles   
     
     
119. ALBULUSHI A, Al-Saidii K, Al-Farhan H
     Impact of Tricuspid Regurgitation Severity on Mortality in Pulmonary Hypertension Patients: A Comprehensive Analysis.
     Curr Probl Cardiol. 2024 Jan 21:102405. doi: 10.1016/j.cpcardiol.2024.102405.
     Abstract     Related articles   
     
     
120. PRADERE P, Le Pavec J, Bos S, Pozza A, et al
     Outcomes of listing for lung and heart-lung transplantation in pulmonary hypertension: comparative experience in France and the UK.
     ERJ Open Res. 2024;10:00521-2023.
     Abstract     Related articles   
     
     
121. ZENG Y, Zhakeer G, Li B, Yu Q, et al
     A novel clinical prediction scoring system of high-altitude pulmonary hypertension.
     Front Cardiovasc Med. 2024;10:1290895.
     Abstract     Related articles   
     
     
122. JASINSKA-STROSCHEIN M
     An updated review of experimental rodent models of pulmonary hypertension and left heart disease.
     Front Pharmacol. 2024;14:1308095.
     Abstract     Related articles   
     
     
123. PADERVINSKIENE L, Azukaite J, Hoppenot D, Krivickiene A, et al
     The Prognostic Value of One-Year Changes in Biventricular Mechanics for Three-Year Survival in Patients with Precapillary Pulmonary Hypertension: A Cardiovascular Magnetic Resonance Feature Tracking Study.
     Medicina (Kaunas). 2024;60:141.
     Abstract     Related articles   
     
     
124. ASENOV K, Dimov R, Kraeva M, Basheva-Kraeva Y, et al
     EUS-Guided Combined Injection Therapy as a Secondary Prophylaxis of Gastric Variceal Bleeding in a Patient Contraindicated for TIPS: Case Report.
     Medicina (Kaunas). 2024;60:116.
     Abstract     Related articles   
     
     
125. AVERJANOVAITE V, Gumbiene L, Zeleckiene I, Sileikiene V, et al
     Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients.
     Medicina (Kaunas). 2023;60:58.
     Abstract     Related articles   
     
     
126. FUKUMOTO Y
     Pathophysiology and Treatment of Pulmonary Arterial Hypertension.
     Int J Mol Sci. 2024;25:1166.
     Abstract     Related articles   
     
     
127. OKAYA T, Kawasaki T, Sato S, Koyanagi Y, et al
     Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.
     Int J Mol Sci. 2024;25:748.
     Abstract     Related articles   
     
     
128. LIU A, Price LC, Sharma R, Wells AU, et al
     Sarcoidosis Associated Pulmonary Hypertension.
     Biomedicines. 2024;12:177.
     Abstract     Related articles   
     
     
129. MASON T, Mukherjee B, Marino P
     Pulmonary Hypertension and the Gut Microbiome.
     Biomedicines. 2024;12:169.
     Abstract     Related articles   
     
     
130. SANTOS EW, Khatoon S, Di Mise A, Zheng YM, et al
     Mitochondrial Dynamics in Pulmonary Hypertension.
     Biomedicines. 2023;12:53.
     Abstract     Related articles   
     
     
131. GHANI H, Pepke-Zaba J
     Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology.
     Biomedicines. 2023;12:46.
     Abstract     Related articles   
     
     
132. YANG KM, Wang MT, Tao CW, Wu YJ, et al
     The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty.
     J Chin Med Assoc. 2024 Jan 22. doi: 10.1097/JCMA.0000000000001059.
     Abstract     Related articles   
     
     
133. HEISS J, Grun K, Singerer I, Tempel L, et al
     Expression of Inflammatory Genes in Murine Lungs in a Model of Experimental Pulmonary Hypertension: Effects of an Antibody-Based Targeted Delivery of Interleukin-9.
     Adv Respir Med. 2024;92:27-35.
     Abstract     Related articles   
     
     
134. LEKANE M, Burnotte P, Gommeren K, Mc Entee K, et al
     Left ventricular eccentricity index to assess precapillary pulmonary hypertension in dogs.
     J Vet Cardiol. 2023;51:220-231.
     Abstract     Related articles   
     
     
135. NUNES H, Brillet PY, Bernaudin JF, Gille T, et al
     Fibrotic Pulmonary Sarcoidosis.
     Clin Chest Med. 2024;45:199-212.
     Abstract     Related articles   
     
     
136. SAVALE L, Dorfmuller P, Boucly A, Jais X, et al
     Sarcoidosis-Associated Pulmonary Hypertension.
     Clin Chest Med. 2024;45:185-197.
     Abstract     Related articles   
     
     
137. KIRKIL G
     Predictors of Mortality in Sarcoidosis.
     Clin Chest Med. 2024;45:175-183.
     Abstract     Related articles   
     
     
138. CHARIF F, Dakroub F, Bou Akl I, Kularatne M, et al
     Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
     Respir Med Res. 2023;84:101053.
     Abstract     Related articles   
     
     
139. DING R, Sang S, Yi J, Xie H, et al
     G6PD is a prognostic biomarker correlated with immune infiltrates in lung adenocarcinoma and pulmonary arterial hypertension.
     Aging (Albany NY). 2024;16:466-492.
     Abstract     Related articles   
     
     
140. AL-HOSNI R, Kaye R, Choi CS, Tammaro P, et al
     The TMEM16A channel as a potential therapeutic target in vascular disease.
     Curr Opin Nephrol Hypertens. 2024;33:161-169.
     Abstract     Related articles   
     
     
141. CHE H, Yi J, Zhao X, Yu H, et al
     Characterization of PKCalpha-rutin interactions and their application as a treatment strategy for pulmonary arterial hypertension by inhibiting ferroptosis.
     Food Funct. 2024;15:779-793.
     Abstract     Related articles   
     
     
142. KOSTYUNINA DS, Pakhomov NV, Jouida A, Dillon E, et al
     Transcriptomics and proteomics revealed sex differences in human pulmonary microvascular endothelial cells.
     Physiol Genomics. 2024;56:194-220.
     Abstract     Related articles   
     
     
143. A X, Huayu M, Li Z, Su S, et al
     In vivo pharmacokinetic study of vanillic acid in monocrotaline-induced pulmonary arterial hypertension rats and its tissue distribution.
     Biomed Chromatogr. 2024;38:e5793.
     Abstract     Related articles   
     
     
144. ERHARDSSON M, Faxen UL, Venkateshvaran A, Hage C, et al
     Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure.
     ESC Heart Fail. 2024;11:601-605.
     Abstract     Related articles   
     
     
145. KAMP JC, Neubert L, Schupp JC, Braubach P, et al
     Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary Dysplasia.
     Am J Pathol. 2024;194:180-194.
     Abstract     Related articles   
     
     
146. MUHLBACHER A, Beaudet A, Brand M, Janssen EM, et al
     Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity.
     Value Health. 2024;27:206-215.
     Abstract     Related articles   
     
     
147. NABEH OA, Saud AI, Amin B, Khedr AS, et al
     A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
     Am J Cardiovasc Drugs. 2024;24:39-54.
     Abstract     Related articles   
     
     
148. DOUGHTY ES, Norvik C, Levin A, Bodmer J, et al
     Long-Term Effect of TBX4 Germline Mutation on Pulmonary Clinico-Histopathologic Phenotype.
     Pediatr Dev Pathol. 2024;27:83-89.
     Abstract     Related articles   
     
     
149. BOXHAMMER E, Dienhart C, Kletzer J, Ramsauer S, et al
     Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females.
     Clin Res Cardiol. 2024;113:138-155.
     Abstract     Related articles   
     
     
150. JHA AK
     Phenotypic characterization of heart failure with preserved ejection fraction.
     Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2996.
     Abstract     Related articles   
     
     
151. SATHIAVAGEESAN S, Shanmugam VB, Sundaram V
     The impact of vascular access location on pulmonary arterial pressure in chronic kidney disease patients undergoing hemodialysis.
     Semin Dial. 2023 Apr 2. doi: 10.1111/sdi.13154.
     Abstract     Related articles   
     
     
152. CRISPINO SP, Segreti A, La Porta Y, Liporace P, et al
     A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise.
     Monaldi Arch Chest Dis. 2023;94.
     Abstract     Related articles   
     
     
153. CHOUDHARY R, Kumari S, Ali M, Thinlas T, et al
     Respiratory tract infection: an unfamiliar risk factor in high-altitude pulmonary edema.
     Brief Funct Genomics. 2024;23:38-45.
     Abstract     Related articles   
     
     
154. ZHU F, de Oliveira CB, Mohsen N, Kharrat A, et al
     Challenges in clinical identification of right ventricular dysfunction in preterm infants with persistent pulmonary hypertension of the newborn.
     Early Hum Dev. 2024;190:105942.
     Abstract     Related articles   
     
     
155. EKICI M, Ileri S, Unaldi E, Bayram GSK, et al
     Are Behcet's disease patients with Budd-Chiari at increased risk for the development of pulmonary hypertension?
     Rheumatology (Oxford). 2024 Feb 1:keae067. doi: 10.1093.
     Abstract     Related articles   
     
     
156. DU P, Gao X, Sun Q, Gong M, et al
     Association between uric acid and cardiac outcomes mediated by neutrophil-to-lymphocyte ratio in patients with left ventricular diastolic dysfunction and pulmonary hypertension.
     Sci Rep. 2024;14:2751.
     Abstract     Related articles   
     
     
157. HANG C, Zu L, Luo X, Wang Y, et al
     Ddx5 Targeted Epigenetic Modification of Pericytes in Pulmonary Hypertension Following Intrauterine Growth Restriction.
     Am J Respir Cell Mol Biol. 2024 Feb 1. doi: 10.1165/rcmb.2023-0244.
     Abstract     Related articles   
     
     
158. VETEL K, Eyries M, Savale L, Kanengiesser C, et al
     Pulmonary Veno-Occlusive Disease and Pulmonary Fibrosis in a Family with EIF2AK4 Pathogenic Variants.
     Am J Respir Cell Mol Biol. 2024;70:143-145.
     Abstract     Related articles   
     
     
159. EL KABBOUT R, Azhar N, Breuils-Bonnet S, Martineau S, et al
     Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking.
     Am J Respir Cell Mol Biol. 2024;70:140-143.
     Abstract     Related articles   
     
     
160. ARSLAN A, Smith J, Qureshi MR, Uysal A, et al
     Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future.
     Front Med (Lausanne). 2024;10:1306032.
     Abstract     Related articles   
     
     
161. STOKES G, Li Z, Talaba N, Genthe W, et al
     Rescuing lung development through embryonic inhibition of histone acetylation.
     Sci Transl Med. 2024;16:eadc8930.
     Abstract     Related articles   
     
     
162. KHAN S, Randhawa S, Patail H, Spira Y, et al
     Pharmacological Update and Emerging Treatments of Pulmonary Hypertension.
     Cardiol Rev. 2024 Jan 31. doi: 10.1097/CRD.0000000000000647.
     Abstract     Related articles   
     
     
163. 
     Correction to: Discrimination Between Pre- and Postcapillary Pulmonary Hypertension Using Platelet RNA.
     J Am Heart Assoc. 2024 Jan 31:e027751. doi: 10.1161/JAHA.122.027751.
     Abstract     Related articles   
     
     
164. SILVA J, Carvoeiro A, Cerqueira P, Calheiros A, et al
     Reversible Pulmonary Hypertension Related to Hyperthyroidism: A Case Report.
     Cureus. 2023;15:e51377.
     Abstract     Related articles   
     
     
165. ZHANG J, Li Q, Liao P, Xiao R, et al
     Calcium sensing receptor: A promising therapeutic target in pulmonary hypertension.
     Life Sci. 2024;340:122472.
     Abstract     Related articles   
     
     
166. PORT SC
     Is there a role for nuclear cardiology in pulmonary hypertension?
     J Nucl Cardiol. 2024;31:101776.
     Abstract     Related articles   
     
     
167. PARIKH R, Thomas A, Sharofi A, Moallem N, et al
     Severe pulmonary hypertension-interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin.
     ERJ Open Res. 2024;10:00659-2023.
     Abstract     Related articles   
     
     
168. BUTERA G, Piccinelli E, Kolesnik A, Averin K, et al
     Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy-an international multicenter case series.
     Front Cardiovasc Med. 2024;10:1332395.
     Abstract     Related articles   
     
     
169. SUN T, Yuan W, Wei Y, Liao D, et al
     The Regulatory Role and Mechanism of Energy Metabolism in Vascular Diseases.
     Front Biosci (Landmark Ed). 2024;29:26.
     Abstract     Related articles   
     
     
170. YANG Y, Huang X, Lin J
     Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis diagnosed after the onset of pulmonary hypertension.
     Int J Rheum Dis. 2024;27:e15027.
     Abstract     Related articles   
     
     
171. EMAMI MEYBODI M, Bamarinejad A, Bamarinejad F, Abhari AP, et al
     Prognostic Implication of Preprocedural Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis.
     Cardiol Rev. 2024 Jan 29. doi: 10.1097/CRD.0000000000000583.
     Abstract     Related articles   
     
     
172. SHI H, Gao P, Liu H, Su J, et al
     Diagnostic value of combined FVC%/DLCO% and echocardiography in connective tissue disorder?associated pulmonary hypertension.
     Med Int (Lond). 2024;4:8.
     Abstract     Related articles   
     
     
173. KIM YJ, Shin SH, Kim EK, Kim HS, et al
     Short term effect of intravenous treprostinil in term and preterm infants with pulmonary hypertension.
     BMC Pediatr. 2024;24:83.
     Abstract     Related articles   
     
     
174. MARTIN MV, Menchero AG, Ferreiro RG, Morist AA, et al
     Expert center and balloon pulmonary angioplasty network program in chronic thromboembolic pulmonary hypertension: safety and effectiveness of a pioneering experience.
     Rev Esp Cardiol (Engl Ed). 2024 Jan 25:S1885-5857(24)00034.
     Abstract     Related articles   
     
     
175. GROSS CR, Varghese R, Zafirova Z
     Perioperative Management of Novel Pharmacotherapies for Heart Failure and Pulmonary Hypertension.
     Anesthesiol Clin. 2024;42:117-130.
     Abstract     Related articles   
     
     
176. NEVES DA SILVA HV, Weinman JP, Englund EK, Deterding RR, et al
     Computed tomographic findings in TBX4 mutation: a common cause of severe pulmonary artery hypertension in children.
     Pediatr Radiol. 2024 Jan 9. doi: 10.1007/s00247-023-05848.
     Abstract     Related articles   
     
     
177. MASOOD M, Singh P, Hariss D, Khan F, et al
     Nitric oxide as a double-edged sword in pulmonary viral infections: Mechanistic insights and potential therapeutic implications.
     Gene. 2024;899:148148.
     Abstract     Related articles   
     
     
178. AHMED HF, Guzman-Gomez A, Desai M, Dani A, et al
     Lung Transplantation for Pulmonary Vascular Disease in Children: A United Network for Organ Sharing Analysis.
     Pediatr Cardiol. 2024;45:385-393.
     Abstract     Related articles   
     
     
179. ROBINSON G, Zielstorff M, Sevilla R, Vanko A, et al
     Multimodal Imaging Reveals that Sustained Inhibition of HIF-Prolyl Hydroxylases Induces Opposing Effects on Right and Left Ventricular Function in Healthy Rats.
     Mol Imaging Biol. 2024;26:179-187.
     Abstract     Related articles   
     
     
180. LI H, Liu S, Dai W, Yao B, et al
     Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema.
     J Control Release. 2024;365:301-316.
     Abstract     Related articles   
     
     
181. KUWAJIMA K, Ogawa M, Ruiz I, Yamane T, et al
     Comparison of prognostic value among echocardiographic surrogates of right ventricular-pulmonary arterial coupling: A three-dimensional echocardiographic study.
     Echocardiography. 2024;41:e15717.
     Abstract     Related articles   
     
     
182. BOUCETTA H, Zhang L, Sosnik A, He W, et al
     Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies.
     J Control Release. 2024;365:236-258.
     Abstract     Related articles   
     
     
183. GILLAM-KRAKAUER M, Reese J
     We Still Don't Know When to Close a Patent Ductus Arteriosus in Very Premature Infants.
     J Pediatr. 2023 Nov 3:113817. doi: 10.1016/j.jpeds.2023.113817.
     Abstract     Related articles   
     
     
184. HUERTAS NIETO S, Velazquez Martin M, Sarnago Cebada F, Jimenez Lopez-Guarch C, et al
     Value of exercise right heart catheterization in the differential diagnosis of chronic thromboembolic pulmonary disease.
     Rev Esp Cardiol (Engl Ed). 2024;77:158-166.
     Abstract     Related articles   
     
     
185. BIEDERMANN P, Sitte-Koch V, Schweiger M, Meinold A, et al
     Pulmonary hemodynamics before and after pediatric heart transplantation.
     Clin Transplant. 2023 Oct 12:e15162. doi: 10.1111/ctr.15162.
     Abstract     Related articles   
     
     
186. ADLY G, Mithoefer O, Elliott Epps J, Hajj JM, et al
     Right Ventricular Contractility and Pulmonary Arterial Coupling After Less Invasive Left Ventricular Assist Device Implantation.
     ASAIO J. 2024;70:99-106.
     Abstract     Related articles   
     
     
187. SAINATHAN S, Ryan J, Mullinari L, Sanchez P, et al
     Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension.
     Clin Transplant. 2024;38:e15158.
     Abstract     Related articles   
     
     
188. FAVERIO P, Paciocco G, Tassistro E, Rebora P, et al
     Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study.
     Intern Emerg Med. 2024;19:183-190.
     Abstract     Related articles   
     
     
189. HUANG J, An Q, Shi H, Li C, et al
     Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients' prognosis.
     Clin Rheumatol. 2023;42:3131-3142.
     Abstract     Related articles   
     
     
190. RANASINGHE ADCU, Tennakoon TMPB, Schwarz MA
     Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension.
     Cells. 2024;13:244.
     Abstract     Related articles   
     
     
191. ZHANG Y, Zhang M, Yang H, Li H, et al
     Serum proteome profiling reveals heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension.
     iScience. 2024;27:108930.
     Abstract     Related articles   
     
     
192. MIN S, Wesselowski SR, Nabity MB, Yankin I, et al
     Pulmonary hypertension is associated with hypocoagulability in dogs: a retrospective analysis of 66 cases (2013-2021).
     Am J Vet Res. 2024 Feb 12:1-8. doi: 10.2460/ajvr.23.11.0252.
     Abstract     Related articles   
     
     
193. FUJII S, Nagayoshi S, Matsumoto T, Miyamoto T, et al
     Spontaneous hemodynamic improvement after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension is observed within a short term after balloon pulmonary angioplasty.
     Cardiovasc Interv Ther. 2024 Feb 8. doi: 10.1007/s12928-024-00987.
     Abstract     Related articles   
     
     
194. KANG Y, Jiang X
     Pregnancy outcomes and risk factors of serious cardiovascular adverse events in pregnant women with pulmonary hypertension.
     Int J Surg. 2024 Feb 8. doi: 10.1097/JS9.0000000000001016.
     Abstract     Related articles   
     
     
195. GAO N, Lv Y, Cui Y, Wang P, et al
     Bosentan in the treatment of persistent pulmonary hypertension in newborns: a systematic review and meta-analysis.
     Cardiol Young. 2024 Feb 8:1-8. doi: 10.1017/S1047951123004456.
     Abstract     Related articles   
     
     
196. WILLEMS L, Kurakula K, Verhaegen J, Klok FA, et al
     Angiogenesis in Chronic Thromboembolic Pulmonary Hypertension: A Janus-Faced Player?
     Arterioscler Thromb Vasc Biol. 2024 Feb 8. doi: 10.1161/ATVBAHA.123.319852.
     Abstract     Related articles   
     
     
197. CHALERMPROMMA P, Surachetpong SD
     Indicators for pulmonary hypertension in dogs with degenerative mitral valve disease.
     Vet World. 2023;16:2515-2520.
     Abstract     Related articles   
     
     
198. QU SS, Li YL, Huang RR, Guo H, et al
     [Impact of hyperoxia on the phenotype of pulmonary artery smooth muscle cells].
     Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:185-190.
     Abstract     Related articles   
     
     
199. HUANG J, Li QY, Ji W, Guo XF, et al
     [Clinical and genetic analysis of a patient with HUPRA syndrome due to missense variants of SARS2 gene and literature review].
     Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:172-179.
     Abstract     Related articles   
     
     
200. JAIN L
     Pulmonary Hypertension of the Newborn.
     Clin Perinatol. 2024;51:xv-xvii.
     Abstract     Related articles   
     
     
201. LAKSHMINRUSIMHA S, Abman SH
     Neonatal Pulmonary Hypertension: Phenotypes, Physiology, and Management.
     Clin Perinatol. 2024;51:xix-xxii.
     Abstract     Related articles   
     
     
202. COOKSON MW, Kinsella JP
     Inhaled Nitric Oxide in Neonatal Pulmonary Hypertension.
     Clin Perinatol. 2024;51:95-111.
     Abstract     Related articles   
     
     
203. LAKSHMINRUSIMHA S, Abman SH
     Oxygen Targets in Neonatal Pulmonary Hypertension: Individualized, "Precision-Medicine" Approach.
     Clin Perinatol. 2024;51:77-94.
     Abstract     Related articles   
     
     
204. BOYD SM, Kluckow M, McNamara PJ
     Targeted Neonatal Echocardiography in the Management of Neonatal Pulmonary Hypertension.
     Clin Perinatol. 2024;51:45-76.
     Abstract     Related articles   
     
     
205. STIEREN ES, Sankaran D, Lakshminrusimha S, Rottkamp CA, et al
     Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension.
     Clin Perinatol. 2024;51:271-289.
     Abstract     Related articles   
     
     
206. COLETTI K, Wild KT, Foglia EE, Otter SC, et al
     Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review.
     Clin Perinatol. 2024;51:253-269.
     Abstract     Related articles   
     
     
207. BANDIYA P, Madappa R, Joshi AR
     Etiology, Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn in Resource-limited Settings.
     Clin Perinatol. 2024;51:237-252.
     Abstract     Related articles   
     
     
208. DANHAIVE O, Galambos C, Lakshminrusimha S, Abman SH, et al
     Pulmonary Hypertension in Developmental Lung Diseases.
     Clin Perinatol. 2024;51:217-235.
     Abstract     Related articles   
     
     
209. YOUNG KC, Schmidt AF, Tan AW, Sbragia L, et al
     Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies.
     Clin Perinatol. 2024;51:21-43.
     Abstract     Related articles   
     
     
210. ABMAN SH, Lakshminrusimha S
     Pulmonary Hypertension in Established Bronchopulmonary Dysplasia: Physiologic Approaches to Clinical Care.
     Clin Perinatol. 2024;51:195-216.
     Abstract     Related articles   
     
     
211. MANI S, Mirza H, Ziegler J, Chandrasekharan P, et al
     Early Pulmonary Hypertension in Preterm Infants.
     Clin Perinatol. 2024;51:171-193.
     Abstract     Related articles   
     
     
212. MOORE SS, Keller RL, Altit G
     Congenital Diaphragmatic Hernia: Pulmonary Hypertension and Pulmonary Vascular Disease.
     Clin Perinatol. 2024;51:151-170.
     Abstract     Related articles   
     
     
213. GEISINGER R, Rios DR, McNamara PJ, Levy PT, et al
     Asphyxia, Therapeutic Hypothermia, and Pulmonary Hypertension.
     Clin Perinatol. 2024;51:127-149.
     Abstract     Related articles   
     
     
214. CARROLL J, Rao R, Steinhorn RH
     Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide.
     Clin Perinatol. 2024;51:113-126.
     Abstract     Related articles   
     
     
215. NABESHIMA Y, Kitano T, Node K, Takeuchi M, et al
     Prognostic value of right ventricular free-wall longitudinal strain in patients with pulmonary hypertension: systematic review and meta-analyses.
     Open Heart. 2024;11:e002561.
     Abstract     Related articles   
     
     
216. CAGUANA-VELEZ OA, Khilzi K, Piccari L, Rodriguez-Sevilla JJ, et al
     Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2.
     Respiration. 2024 Feb 7:1-9. doi: 10.1159/000536064.
     Abstract     Related articles   
     
     
217. WANG J, Kuang J, Zhang S, Liu Z, et al
     Comprehensive characterization of small noncoding RNA profiles in hypoxia-induced pulmonary hypertension (HPH) rat tissues.
     iScience. 2024;27:108815.
     Abstract     Related articles   
     
     
218. ALKHATEEBALTAMIMI D, Khalidi K, Khasawneh R, Alzaben A, et al
     Recurrent Syncope Unveiling Pulmonary Hypertension Secondary to Pulmonary Artery Thrombi in a Pediatric Patient.
     Cureus. 2024;16:e51812.
     Abstract     Related articles   
     
     
219. GAYEN SK, Zulty M, Criner GJ
     Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis.
     Respir Res. 2024;25:79.
     Abstract     Related articles   
     
     
220. ANDERSON J, Grell R, Haines D
     Anaesthetic management of a patient with severe pulmonary hypertension, moderate tricuspid regurgitation and moderate right ventricular dysfunction presenting for a dilation and curettage.
     BMJ Case Rep. 2024;17:e257225.
     Abstract     Related articles   
     
     
221. DWIVEDI K, Sharkey M, Delaney L, Alabed S, et al
     Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CT.
     Radiology. 2024;310:e231718.
     Abstract     Related articles   
     
     
222. ZHENG H, Wu D, Chen X, He W, et al
     Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
     Heliyon. 2024;10:e24963.
     Abstract     Related articles   
     
     
223. AHMED S, Ahmed A, Radegran G
     Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
     Pulm Circ. 2024;14:e12340.
     Abstract     Related articles   
     
     
224. OSTASEVICIUS V, Jurenas V, Venslauskas M, Kizauskiene L, et al
     Low-frequency ultrasound for pulmonary hypertension therapy.
     Respir Res. 2024;25:70.
     Abstract     Related articles   
     
     
225. COMARITA IK, Tanko G, Anghelache IL, Georgescu A, et al
     The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
     J Transl Med. 2024;22:137.
     Abstract     Related articles   
     
     
226. ZHANG J, Zhang Y, Yin Y, Feng Y, et al
     'Fear, uncertain, tired......' psychological distress among pulmonary hypertension patients: a qualitative interview study.
     BMC Psychiatry. 2024;24:100.
     Abstract     Related articles   
     
     
227. HINZE CA, Park DH, Bollmann BA
     Pulmonary Artery Aneurysm in Longstanding Idiopathic Pulmonary Arterial Hypertension.
     Dtsch Arztebl Int. 2023;120.
     Abstract     Related articles   
     
     
228. BENSLIMANE Z, Yavuz S, Francis N
     A rare presentation of childhood interstitial lung disease attributed to KDM3B gene mutation: a case report.
     Pan Afr Med J. 2023;46:84.
     Abstract     Related articles   
     
     
229. BRANESCU I, Vladareanu S, Shetty S, Alexandru DO, et al
     Sildenafil in Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: Friend or Foe?
     Curr Health Sci J. 2023;49:319-324.
     Abstract     Related articles   
     
     
230. BATTA A, Hatwal J
     Development of pulmonary hypertension remains a major hurdle to corrective surgery in Down syndrome.
     World J Cardiol. 2024;16:1-4.
     Abstract     Related articles   
     
     
231. KASSA B, Fonseca-Balladares DC, Kumar R, Lee MH, et al
     Experimental Schistosoma haematobium pulmonary hypertension.
     Pulm Circ. 2024;14:e12336.
     Abstract     Related articles   
     
     
232. WANG W, Gong JN, Wang JF, Ding Y, et al
     [Hemodynamic changes with serial balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension].
     Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:120-125.
     Abstract     Related articles   
     
     
233. ANAND V, Weston AD, Scott CG, Kane GC, et al
     Machine Learning for Diagnosis of Pulmonary Hypertension by Echocardiography.
     Mayo Clin Proc. 2024;99:260-270.
     Abstract     Related articles   
     
     
234. JIANG G, Shi LF, Li LJ, Duan XJ, et al
     Activation of the p62-Keap1-Nrf2 pathway improves pulmonary arterial hypertension in MCT-induced rats by inhibiting autophagy.
     FASEB J. 2024;38:e23452.
     Abstract     Related articles   
     
     
235. LAN WF, Deng Y, Dai P, Wu DD, et al
     Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
     Lupus. 2024;33:155-165.
     Abstract     Related articles   
     
     
236. LI MH, Liu X, Xie YL, Tang XG, et al
     Sodium butyrate alleviates right ventricular hypertrophy in pulmonary arterial hypertension by inhibiting H19 and affecting the activation of let-7g-5p/IGF1 receptor/ERK.
     Eur J Pharmacol. 2024 Jan 2:176315. doi: 10.1016/j.ejphar.2024.176315.
     Abstract     Related articles   
     
     
237. LU J, Alenezi F, Bier E, Leewiwatwong S, et al
     Optimized quantitative mapping of cardiopulmonary oscillations using hyperpolarized (129) Xe gas exchange MRI: Digital phantoms and clinical evaluation in CTEPH.
     Magn Reson Med. 2024;91:1541-1555.
     Abstract     Related articles   
     
     
238. LIU Q, Yang Y, Wu M, Wang M, et al
     Hub gene ELK3-mediated reprogramming lipid metabolism regulates phenotypic switching of pulmonary artery smooth muscle cells to develop pulmonary arterial hypertension induced by PM(2.5).
     J Hazard Mater. 2024;465:133190.
     Abstract     Related articles   
     
     
239. GRUNIG E, Rahaghi F, Elwing J, Vizza CD, et al
     Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.
     Adv Ther. 2024;41:618-637.
     Abstract     Related articles   
     
     
240. KIM D, Choi KH, Kim H, Lee JH, et al
     Right lower lung midline herniation as a rare complication in an infant with heart-lung transplantation: A case report.
     Pediatr Transplant. 2024;28:e14656.
     Abstract     Related articles   
     
     
241. XANTHOULI P, Echampati I, Lorenz HM, Heussel CP, et al
     Respiratory involvement in connective tissue diseases.
     Eur J Intern Med. 2024;120:11-16.
     Abstract     Related articles   
     
     
242. REYES-HERNANDEZ ME, Bischoff AR, Giesinger RE, Rios DR, et al
     Echocardiography Assessment of Left Ventricular Function in Extremely Preterm Infants, Born at Less Than 28 Weeks' Gestation, With Bronchopulmonary Dysplasia and Systemic Hypertension.
     J Am Soc Echocardiogr. 2024;37:237-247.
     Abstract     Related articles   
     
     
243. KOPEC G, Araszkiewicz A, Magon W, Stepniewski J, et al
     Results of atrial flow regulator implantation in pulmonary arterial hypertension patients with severe heart failure despite maximal medical therapy.
     Kardiol Pol. 2024;82:75-78.
     Abstract     Related articles   
     
     
244. SHI S, Zhu X, Cheang I, Liao S, et al
     Development and validation of a diagnostic nomogram in pulmonary hypertension due to left heart disease.
     Heart Lung. 2024;65:11-18.
     Abstract     Related articles   
     
     
245. MURAKAMI T, Ohno Y, Horinouchi H, Noda S, et al
     Vericiguat and transcatheter edge-to-edge mitral valve repair for combined post- and pre-capillary pulmonary hypertension due to left ventricular low ejection fraction and functional mitral regurgitation.
     J Cardiol Cases. 2023;29:78-81.
     Abstract     Related articles   
     
     
246. SHARMA S, Antoniak S
     New Insights in the Pathology of Chronic Thromboembolic Pulmonary Hypertension.
     JACC Basic Transl Sci. 2024;9:117-119.
     Abstract     Related articles   
     
     
247. SMALL M, Perchenet L, Bennett A, Linder J, et al
     The diagnostic journey of pulmonary arterial hypertension patients: results from a multinational real-world survey.
     Ther Adv Respir Dis. 2024;18:17534666231218886.
     Abstract     Related articles   
     
     
248. DUENAS-MEZA E, Severiche-Bueno DF, Santos Quintero C, Talani Ochoa J, et al
     Prevalence of pulmonary hypertension in children with obstructive sleep apnea living at high altitude.
     Sleep Med X. 2024;7:100106.
     Abstract     Related articles   
     
     
249. ROSEN C, Jacqmart C, Charlier C, Beghetti M, et al
     [Risks of magistral preparations in pediatrics].
     Rev Med Liege. 2024;79:104-109.
     Abstract     Related articles   
     
     
250. GARRETT ME, Foster MW, Telen MJ, Ashley-Koch AE, et al
     Nontargeted Plasma Proteomic Analysis of Renal Disease and Pulmonary Hypertension in Patients with Sickle Cell Disease.
     J Proteome Res. 2024 Feb 14. doi: 10.1021/acs.jproteome.3c00748.
     Abstract     Related articles   
     
     
251. PEER SB, Loor G, Han JW, Shafii AE, et al
     Surgical right pulmonary artery to left atrial shunt for severe pulmonary hypertension and bridge to lung transplantation.
     JTCVS Tech. 2023;23:178-181.
     Abstract     Related articles   
     
     
252. DEBOEVER N, Eapen GA, Casal RF, Durand JB, et al
     Endobronchial ultrasound: A novel screening test for pulmonary hypertension prior to major pulmonary surgery.
     JTCVS Tech. 2023;23:146-153.
     Abstract     Related articles   
     
     
253. YOSHIDA S, Eichelberger O, Ulis M, Kreger AM, et al
     Intra-Amniotic Sildenafil and Rosiglitazone Late in Gestation Ameliorate the Pulmonary Hypertension Phenotype in Congenital Diaphragmatic Hernia.
     J Pediatr Surg. 2024 Jan 23:S0022-3468(24)00017.
     Abstract     Related articles   
     
     
254. YIM IHW, Parker KH, Drury NE, Lim HS, et al
     Pulmonary artery wave intensity analysis in pulmonary hypertension associated with heart failure and reduced left ventricular ejection fraction.
     Pulm Circ. 2024;14:e12345.
     Abstract     Related articles   
     
     
255. ZHOU J, Guo D, Xu ZZ, Liao JS, et al
     Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension.
     Cell Biol Toxicol. 2024;40:13.
     Abstract     Related articles   
     
     
256. DEL VALLE KT, Krowka MJ, Schinstock CA, Nath KA, et al
     Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study.
     Pulm Circ. 2024;14:e12341.
     Abstract     Related articles   
     
     
257. BAILEY ME, Durst L, Cajigas HR, Kane GC, et al
     Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease.
     Pulm Circ. 2024;14:e12343.
     Abstract     Related articles   
     
     
258. FAKHRY B, Peterson L, Comhair SAA, Sharp J, et al
     Blood Cholesterol and Triglycerides Associate with Right Ventricular Function in Pulmonary Hypertension.
     medRxiv. 2024 Jan 22:2024.01.20.24301498. doi: 10.1101/2024.01.20.24301498.
     Abstract     Related articles   
     
     
259. OWUSU IK, Amponsah GM, Wiafe YA
     Severe Pulmonary Hypertension From Combined Ventricular Septal Defect and Rheumatic MIitral Valve Disease: A Case Report and Literature Review.
     Clin Med Insights Case Rep. 2024;17:11795476241231140.
     Abstract     Related articles   
     
     
260. CUETO-ROBLEDO G, Cantero-Ceballos MD, Gonzalez-Hermosillo LM, Navarro-Vergara DI, et al
     Severe Pulmonary Hypertension in Pulmonary Alveolar Microlithiasis: A Comprehensive Literature Review.
     Curr Probl Cardiol. 2024 Feb 9:102453. doi: 10.1016/j.cpcardiol.2024.102453.
     Abstract     Related articles   
     
     
261. LEE J, Cho DH, Min HJ, Son YB, et al
     Higher sclerostin is associated with pulmonary hypertension in pre-dialysis end-stage kidney disease patients: a cross-sectional prospective observational cohort study.
     BMC Pulm Med. 2024;24:78.
     Abstract     Related articles   
     
     
262. INOUE K, Andersen OS, Remme EW, Khan FH, et al
     Echocardiographic Evaluation of Left Ventricular Filling Pressure in Patients With Pulmonary Hypertension.
     JACC Cardiovasc Imaging. 2024 Jan 28:S1936-878X(24)00024.
     Abstract     Related articles   
     
     
263. VAIDY A, Vahdatpour CA, Mazurek J
     Exercise Testing in Patients with Pulmonary Hypertension.
     J Clin Med. 2024;13:795.
     Abstract     Related articles   
     
     
264. BIGDELU L, Alimi H, Fazlinezhad A, Ghaderi F, et al
     Novel echocardiographic parameters in pulmonary hypertension assessment and the relationship between echocardiography and 6-minute walking test.
     Medicine (Baltimore). 2024;103:e35294.
     Abstract     Related articles   
     
     
265. MOURA DE AZEVEDO S, Furtado I, Carvalho L, Reis A, et al
     10-year success story in CTEPH treatment: breaking the myth of rareness.
     BMJ Case Rep. 2024;17:e257942.
     Abstract     Related articles   
     
     
266. RAHIMI M, Rahimi S, Karimi Torshizi MA, Sharafi M, et al
     The effect of peroxisome proliferator-activated receptor gamma (PPARgamma) as a mediator of dietary fatty acids and thiazolidinedione in pulmonary arterial hypertension induced by cold stress of broilers.
     Res Vet Sci. 2024;168:105157.
     Abstract     Related articles   
     
     
267. KIM H, Liu Y, Kim J, Kim Y, et al
     Pericytes contribute to pulmonary vascular remodeling via HIF2alpha signaling.
     EMBO Rep. 2024;25:616-645.
     Abstract     Related articles   
     
     
268. HAN PL, Jiang L, Cheng JL, Shi K, et al
     Artificial intelligence-assisted diagnosis of congenital heart disease and associated pulmonary arterial hypertension from chest radiographs: A multi-reader multi-case study.
     Eur J Radiol. 2023;171:111277.
     Abstract     Related articles   
     
     
269. BOBROVSKI VG, Pinheiro AL, de-Castro JAL, Rech EB, et al
     Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil.
     Curr Probl Cardiol. 2024;49:102340.
     Abstract     Related articles   
     
     
270. BENINCASA G, Strozziero MG, Trama U, Napoli C, et al
     Unsolved Issues on Beneficial Effects of Combination Therapy With Sotatercept in Pulmonary Arterial Hypertension.
     Heart Lung Circ. 2024;33:12-13.
     Abstract     Related articles   
     
     
271. KIPFMUELLER F, Leyens J, Pugnaloni F, Bo B, et al
     Spontaneous breathing in selected neonates with very mild congenital diaphragmatic hernia.
     Pediatr Pulmonol. 2023 Nov 29. doi: 10.1002/ppul.26791.
     Abstract     Related articles   
     
     
272. EDEL GG, Hol JA, Slot E, von der Thusen JH, et al
     Clinical Relevance of Rapid FOXF1-Targeted Sequencing in Patients Suspected of Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins.
     Lab Invest. 2023;103:100233.
     Abstract     Related articles   
     
     
273. OKNINSKA M, Zajda K, Zambrowska Z, Grzanka M, et al
     Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension.
     JACC Heart Fail. 2024;12:235-247.
     Abstract     Related articles   
     
     
274. OKUNUSHI K, Kobayashi H, Yoh Y, Kunimatsu M, et al
     A case report of a child with pulmonary hypertension associated with SARS-CoV-2 infection.
     Front Pediatr. 2024;12:1336589.
     Abstract     Related articles   
     
     
275. BOLLOVA D, Reptova A, Valkovicova T, Gazdikova K, et al
     Risk of chronic thromboembolic pulmonary hypertension after splenectomy.
     Bratisl Lek Listy. 2024;125:176-182.
     Abstract     Related articles   
     
     
276. SATO S, Ito T, Tabata T, Ogawa A, et al
     Corrigendum: Effect of balloon pulmonary angioplasty on cardio-ankle vascular index and biventricular remodeling in patients with chronic thromboembolic pulmonary hypertension.
     Front Cardiovasc Med. 2024;11:1377556.
     Abstract     Related articles   
     
     
277. KOPEC G, Forfia P, Abe K, Beaudet A, et al
     Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
     Pulm Circ. 2024;14:e12330.
     Abstract     Related articles   
     
     
278. LIN P, Jiang F, Li X, Zhao Y, et al
     International trends in pulmonary hypertension mortality between 2001 and 2019: Retrospective analysis of the WHO mortality database.
     Heliyon. 2024;10:e26139.
     Abstract     Related articles   
     
     
279. MULLER J, Appenzeller P, Lichtblau M, Saxer S, et al
     Effects of 5-Week Oral Acetazolamide on Incremental Cycling Exercise in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension: A Randomized Placebo-Controlled, Double-Blinded, Crossover Trial.
     Respiration. 2024 Feb 21:1-10. doi: 10.1159/000536399.
     Abstract     Related articles   
     
     
280. ONGEN HG, Akdeniz B, Duzenli MA, Chernyavsky A, et al
     Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study.
     Drugs Real World Outcomes. 2024 Feb 21. doi: 10.1007/s40801-023-00407.
     Abstract     Related articles   
     
     
281. SHEN T, Shi J, Zhao X, Fu L, et al
     Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular Remodeling.
     Am J Respir Cell Mol Biol. 2024 Feb 21. doi: 10.1165/rcmb.2022-0426.
     Abstract     Related articles   
     
     
282. ZHANG W, Li M, Ye X, Jiang M, et al
     Disturbance of mitochondrial dynamics in myocardium of broilers with pulmonary hypertension syndrome.
     Br Poult Sci. 2024 Feb 21:1-11. doi: 10.1080/00071668.2024.2308277.
     Abstract     Related articles   
     
     
283. MIAO H, Hui H, Fan W, Lin Y, et al
     Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia.
     Biomed Pharmacother. 2024;172:116303.
     Abstract     Related articles   
     
     
284. LI K, Shen C, Wen N, Han Y, et al
     EPO regulates the differentiation and homing of bone marrow mesenchymal stem cells through Notch1/Jagged pathway to treat pulmonary hypertension.
     Heliyon. 2024;10:e25234.
     Abstract     Related articles   
     
     
285. MINAMITANI Y, Kato S, Hosokawa M, Nakashima T, et al
     Inhaled nitric oxide therapy for preterm infants after 7 days of age: a scoping review protocol.
     BMJ Open. 2024;14:e080298.
     Abstract     Related articles   
     
     
286. HOSKING M, Bates A
     Therapy in pediatric pulmonary hypertension: memoire of an unfinished journey.
     Can J Cardiol. 2024 Feb 17:S0828-282X(24)00173.
     Abstract     Related articles   
     
     
287. FUJII S, Nagayoshi S, Miyamoto T, Ogawa K, et al
     The beneficial effects of balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension are accompanied by increased body mass index and improved nutritional status.
     Pulm Circ. 2024;14:e12347.
     Abstract     Related articles   
     
     
288. LIU B, Yi D, Li S, Ramirez K, et al
     Endothelial fatty acid-binding proteins contribute to the pathogenesis of pulmonary hypertension.
     bioRxiv [Preprint]. 2024 Feb 11:2024.02.11.579846.
     Abstract     Related articles   
     
     
289. DUARTE AC, Alegria S, Vinagre F, Ferreira F, et al
     Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?
     ARP Rheumatol. 2024.
     Abstract     Related articles   
     
     
290. KASHIWADA T, Tanaka Y, Tanaka T, Okano T, et al
     Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention-prospective, single-center, randomized, pa
     BMC Pulm Med. 2024;24:90.
     Abstract     Related articles   
     
     
291. DAI L, Chen Y, Wu J, He Z, et al
     A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
     J Transl Med. 2024;22:164.
     Abstract     Related articles   
     
     
292. TORBIC H, Tonelli AR
     Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting.
     J Cardiovasc Pharmacol Ther. 2024;29:10742484231225310.
     Abstract     Related articles   
     
     
293. MULLER A, Escribano-Subias P, Fernandes CC, Fontana M, et al
     Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE.
     Adv Ther. 2024;41:1103-1119.
     Abstract     Related articles   
     
     
294. BARBERA J, Jansa P, Klings E, Ristic A, et al
     Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension.
     Adv Ther. 2024;41:1062-1074.
     Abstract     Related articles   
     
     
295. LEWIS MI, Shapiro S, Oudiz RJ, Nakamura M, et al
     The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.
     EBioMedicine. 2024;100:104900.
     Abstract     Related articles   
     
     
296. LIAO K, Mackenzie H, Ait-Oudhia S, Manimaran S, et al
     The Impact of Immunogenicity on the Pharmacokinetics, Efficacy, and Safety of Sotatercept in a Phase III Study of Pulmonary Arterial Hypertension.
     Clin Pharmacol Ther. 2024;115:478-487.
     Abstract     Related articles   
     
     
297. SCHONFELD T, Seitz P, Krieghoff C, Ponorac S, et al
     High-pitch CT pulmonary angiography (CTPA) with ultra-low contrast medium volume for the detection of pulmonary embolism: a comparison with standard CTPA.
     Eur Radiol. 2023 Sep 1. doi: 10.1007/s00330-023-10101.
     Abstract     Related articles   
     
     
298. DING W, Gu Y, Wang H, Wu H, et al
     Prenatal MRI assessment of mediastinal shift angle as a feasible and effective risk stratification tool in isolated right-sided congenital diaphragmatic hernia.
     Eur Radiol. 2024;34:1524-1533.
     Abstract     Related articles   
     
     
299. SESHADRI N, Kim LY, McGrath-Morrow SA, Collaco JM, et al
     Human Milk Cessation in the NICU in Infants with Bronchopulmonary Dysplasia.
     Am J Perinatol. 2021 Nov 9. doi: 10.1055/a-1692-0796.
     Abstract     Related articles   
     
     
300. BARTAKKE AA, Saez de Ibarra Sanchez JI
     Successful perioperative management of a primary pulmonary arterial angiosarcoma: case report.
     Braz J Anesthesiol. 2024;74:744186.
     Abstract     Related articles   
     
     
301. JOYE S, Bhattacharya S, Kharrat A, Jasani B, et al
     Shape of Pulmonary Artery Doppler Flow Profile and Right Ventricular Hemodynamics in Neonates.
     J Pediatr. 2023 Dec 3:113864. doi: 10.1016/j.jpeds.2023.113864.
     Abstract     Related articles   
     
     
302. BATRA J, Mourad M, Collado FK, Takeda K, et al
     Case report of pregnancy complicated by severe pulmonary hypertension from mitral stenosis and placenta accreta spectrum disorder: management of two life-threatening conditions.
     Eur Heart J Case Rep. 2024;8:ytae055.
     Abstract     Related articles   
     
     
303. MUELLER-GRAF F, Frenkel P, Merz J, Reuter S, et al
     Respiratory gating improves correlation between pulse wave transit time and pulmonary artery pressure in experimental pulmonary hypertension.
     Physiol Meas. 2024 Feb 29. doi: 10.1088/1361-6579.
     Abstract     Related articles   
     
     
304. ISHIZU T, Hayashi Y, Tokushige N, Omura J, et al
     Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan.
     Curr Med Res Opin. 2024 Feb 29:1-13. doi: 10.1080/03007995.2024.2323632.
     Abstract     Related articles   
     
     
305. IVARSSON B, Johansson A, Kjellstrom B
     Change in health-related quality of life at early follow-up in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
     Pulm Circ. 2024;14:e12349.
     Abstract     Related articles   
     
     
306. SOLTANI HEKMAT A, Amini F, Javanmardi K
     Effects of alamandine on monocrotaline-induced pulmonary hypertension in rats.
     Iran J Basic Med Sci. 2024;27:500-508.
     Abstract     Related articles   
     
     
307. ARANGO-GRANADOS MC, Osorio-Gonzalez LJ, Munoz-Patino V
     Bedside Ultrasound to Guide the Diagnosis and Treatment of Fulminant Right Heart Failure: A Case Report.
     Am J Case Rep. 2024;25:e942694.
     Abstract     Related articles   
     
     
308. VAN DE VEERDONK MC, Roosma L, Trip P, Gopalan D, et al
     Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
     Eur Respir Rev. 2024;33:230144.
     Abstract     Related articles   
     
     
309. GAO X, Jiang X, Wu Z, Chen N, et al
     Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.
     J Interv Cardiol. 2024;2024:4512655.
     Abstract     Related articles   
     
     
310. WANG Y, Zhu Z, Niu L, Liu B, et al
     Geometric remodeling of tricuspid valve in pulmonary hypertension and its correlation with pulmonary hypertension severity: a prospectively case-control study using four-dimensional automatic tricuspid valve quantification technology.
     Quant Imaging Med Surg. 2024;14:1699-1715.
     Abstract     Related articles   
     
     
311. IMAI S, Sakao S, Nagata J, Naito A, et al
     Artificial intelligence-based model for predicting pulmonary arterial hypertension on chest x-ray images.
     BMC Pulm Med. 2024;24:101.
     Abstract     Related articles   
     
     
312. PAEZ-CARPIO A, Vollmer I, Zarco FX, Matute-Gonzalez M, et al
     Imaging of chronic thromboembolic pulmonary hypertension before, during and after balloon pulmonary angioplasty.
     Diagn Interv Imaging. 2024 Feb 26:S2211-5684(24)00040.
     Abstract     Related articles   
     
     
313. LI M, Shang X, Lou H, Wang Z, et al
     Active Anchoring Stimuli-responsive Nano-craft to relieve Pulmonary Vasoconstriction by Targeting Smooth Muscle Cell for Hypoxic Pulmonary Hypertension Treatment.
     Adv Healthc Mater. 2024 Feb 27:e2400113. doi: 10.1002/adhm.202400113.
     Abstract     Related articles   
     
     
314. VATRANO M, Manzi G, Picariello C, D'Alto M, et al
     [ANMCO/SIC Consensus statement on pulmonary arterial hypertension].
     G Ital Cardiol (Rome). 2024;25:192-201.
     Abstract     Related articles   
     
     
315. DENG W, Guo W, Yang A, Lin D, et al
     A better method to evaluate the reliability of echocardiography for assessment of pulmonary hypertension: comparison of tricuspid regurgitant spectrum quality grading and tricuspid valve regurgitation degree.
     J Thorac Dis. 2024;16:51-64.
     Abstract     Related articles   
     
     
316. KIMYON AS, Cetinkaya A, Hallioglu Kilinc O, Aras N, et al
     The evaluation of the SMAD1 rs1016792 polymorphism and gene expression on pulmonary hypertension due to congenital heart disease in children: a preliminary study.
     Nucleosides Nucleotides Nucleic Acids. 2024.
     Abstract     Related articles   
     
     
317. NAKANO T, Wada S, Nishisako R, Sakurai Y, et al
     Massive hemoptysis from a bronchial-pulmonary arterial fistula.
     Pediatr Int. 2024;66:e15741.
     Abstract     Related articles   
     
     
318. ESTRADA RA, Auger WR, Sahay S
     Chronic Thromboembolic Pulmonary Hypertension.
     JAMA. 2024 Feb 26. doi: 10.1001/jama.2023.24265.
     Abstract     Related articles   
     
     
319. HRYZHAK I, Pryshliak O, Kobryn T, Fedorov S, et al
     Clinical and echocardiographic findings in patients with COVID-19 across different severity levels.
     J Med Life. 2023;16:1692-1700.
     Abstract     Related articles   
     
     
320. JI XY, Lei CJ, Kong S, Li HF, et al
     Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension.
     Drug Des Devel Ther. 2024;18:475-491.
     Abstract     Related articles   
     
     
321. YANG X, Sun J, Yang H, Guo T, et al
     [Diagnosis of pulmonary hypertension associated with congenital heart disease based on statistical features of the second heart sound].
     Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024;41:41-50.
     Abstract     Related articles   
     
     
322. SANIVARAPU RR, Arjun S, Otero J, Munshi R, et al
     In-hospital outcomes of pulmonary hypertension in HIV patients: A population based cohort study.
     Int J Cardiol. 2024 Feb 23:131900. doi: 10.1016/j.ijcard.2024.131900.
     Abstract     Related articles   
     
     
323. KENNEWEG F, Hobohm L, Bang C, Gupta SK, et al
     Circulating miR-let7a levels predict future diagnosis of chronic thromboembolic pulmonary hypertension.
     Sci Rep. 2024;14:4514.
     Abstract     Related articles   
     
     
324. KAYALI SM, Dietz BE 2nd, Siddiq BS, Ghaly M, et al
     Chronic thromboembolic pulmonary hypertension and balloon pulmonary angioplasty - Where are we in 2024?
     Curr Probl Cardiol. 2024;49:102481.
     Abstract     Related articles   
     
     
325. FOROSHANI S, Airo M, Levine A, Frishman WH, et al
     COVID-19 and Pulmonary Hypertension: An Interesting Dynamic.
     Cardiol Rev. 2024 Feb 24. doi: 10.1097/CRD.0000000000000679.
     Abstract     Related articles   
     
     
326. MERELES D, Rudolph J, Greiner S, Aurich M, et al
     Acute changes in cardiac dimensions, function, and longitudinal mechanics in healthy individuals with and without high-altitude induced pulmonary hypertension at 4559 m.
     Echocardiography. 2024;41:e15786.
     Abstract     Related articles   
     
     
327. EREMINIENE E, Stuoka M, Ordiene R, Plisiene J, et al
     Acquired Cardiovascular Diseases in Patients with Pulmonary Hypertension Due to Congenital Heart Disease: A Case Report.
     Medicina (Kaunas). 2024;60:266.
     Abstract     Related articles   
     
     
328. GONCHAROVA N, Lapshin K, Berezina A, Simakova M, et al
     Elderly Patients with Idiopathic Pulmonary Hypertension: Clinical Characteristics, Survival, and Risk Stratification in a Single-Center Prospective Registry.
     Life (Basel). 2024;14:259.
     Abstract     Related articles   
     
     
329. WEI ZX, Cai XX, Fei YD, Wang Q, et al
     Ntsr1 contributes to pulmonary hypertension by enhancing endoplasmic reticulum stress via JAK2-STAT3-Thbs1 signaling.
     Transl Res. 2024 Feb 21:S1931-5244(24)00031-8. doi: 10.1016/j.trsl.2024.
     Abstract     Related articles   
     
     
330. WANG Y, Rong C, Liu J, Liu X, et al
     Pulmonary arterial sarcoma: A case report.
     Medicine (Baltimore). 2024;103:e37194.
     Abstract     Related articles   
     
     
331. ASAL AEA, Oshaiba ZF, Mansour ENA, Abd Elaziz OH, et al
     Serum pentraxin 3 levels in term neonates with persistent pulmonary hypertension.
     J Neonatal Perinatal Med. 2024 Feb 21. doi: 10.3233/NPM-230211.
     Abstract     Related articles   
     
     
332. SEKI N, Tsujimoto H, Tanemura S, Ishigaki S, et al
     Th17/IL-17A axis is critical for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc): SSc patients with high levels of serum IL-17A exhibit reduced lung functions and increased prevalence of PAH.
     Cytokine. 2024;176:156534.
     Abstract     Related articles   
     
     
333. TANG L, Zhou X, Guo A, Han L, et al
     Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling.
     Cardiovasc Toxicol. 2024;24:158-170.
     Abstract     Related articles   
     
     
334. PICCINELLI E, Frazzetto F, Pilati M, Butera G, et al
     Stent Implantation Across the Atrial Flow Regulator Device.
     Pediatr Cardiol. 2024;45:695-698.
     Abstract     Related articles   
     
     
335. LIPCZYNSKA M, Derejska M, Swierczynski R, Kusmierczyk-Droszcz B, et al
     Noncardiac surgery in Eisenmenger syndrome.
     Pol Arch Intern Med. 2024;134:16652.
     Abstract     Related articles   
     
     
336. CONNES P
     Blood rheology and vascular function in sickle cell trait and sickle cell disease: From pathophysiological mechanisms to clinical usefulness.
     Clin Hemorheol Microcirc. 2024;86.
     Abstract     Related articles   
     
     
337. JIA Q, Ouyang Y, Yang Y, Yao S, et al
     Osteopontin: A Novel Therapeutic Target for Respiratory Diseases.
     Lung. 2024;202:25-39.
     Abstract     Related articles   
     
     
338. LIN K, Sarnari R, Gordon DZ, Markl M, et al
     Cine MRI-derived radiomics features indicate hemodynamic changes in the pulmonary artery.
     Int J Cardiovasc Imaging. 2024;40:287-294.
     Abstract     Related articles   
     
     
339. FULOP P, Valocik G, Barbierik Vachalcova M, Zenuch P, et al
     Aortic stenosis and right ventricular dysfunction.
     Int J Cardiovasc Imaging. 2024;40:299-305.
     Abstract     Related articles   
     
     
340. CAIN MT, Schafer M, Park S, Barker AJ, et al
     Characterization of pulmonary arterial stiffness using cardiac MRI.
     Int J Cardiovasc Imaging. 2024;40:425-439.
     Abstract     Related articles   
     
     
341. ANASTASIOU V, Papazoglou AS, Moysidis DV, Daios S, et al
     The prognostic impact of right ventricular-pulmonary arterial coupling in heart failure: a systematic review and meta-analysis.
     Heart Fail Rev. 2024;29:13-26.
     Abstract     Related articles   
     
     
342. SONG J, Chen Y, Chen Y, Wang S, et al
     Ferrostatin-1 Blunts Right Ventricular Hypertrophy and Dysfunction in Pulmonary Arterial Hypertension by Suppressing the HMOX1/GSH Signaling.
     J Cardiovasc Transl Res. 2024;17:183-196.
     Abstract     Related articles   
     
     
343. CHAO C, Wang M, Mei K, Ma C, et al
     An inverse causal relationship between serum 25-hydroxyvitamin D levels and pulmonary hypertension: A two-sample Mendelian randomization study.
     Pulm Circ. 2024;14:e12350.
     Abstract     Related articles   
     
     
344. TERUI Y, Ohura S, Nozaki T, Yagi T, et al
     Pulmonary hypertension in an adult patient with congenital central hypoventilation syndrome: a case report.
     Eur Heart J Case Rep. 2024;8:ytae109.
     Abstract     Related articles   
     
     
345. LI X, Zhang Y, Zhang S, Zhao Q, et al
     Tumor biomarkers in evaluating the severity and prognosis of idiopathic pulmonary arterial hypertension: A comprehensive analysis.
     Clin Transl Sci. 2024;17:e13751.
     Abstract     Related articles   
     
     
346. KAVGACI A, Kula S, Berber Marasli E, Zinnuroglu M, et al
     Evaluation of handgrip strength in children with pulmonary hypertension.
     Cardiol Young. 2024 Mar 7:1-5. doi: 10.1017/S1047951124000398.
     Abstract     Related articles   
     
     
347. WU XF, Sun TT, Lin JL, Guo WL, et al
     [Pulmonary artery stenting in chronic thromboembolic pulmonary hypertension: a report of 2 cases].
     Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:228-232.
     Abstract     Related articles   
     
     
348. MESSIKA J, Eloy P, Boulate D, Charvet A, et al
     Protocol for venoarterial ExtraCorporeal Membrane Oxygenation to reduce morbidity and mortality following bilateral lung TransPlantation: the ECMOToP randomised controlled trial.
     BMJ Open. 2024;14:e077770.
     Abstract     Related articles   
     
     
349. WANG Y, Guo D, Gong J, Wang J, et al
     Efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with pulmonary comorbidity.
     Int J Cardiol Heart Vasc. 2024;51:101363.
     Abstract     Related articles   
     
     
350. PILIERO N, Salvat M, Finas M, Curioz F, et al
     Upfront triple therapy with parenteral prostanoid as a bridge to balloon pulmonary angioplasty in severe chronic thromboembolic pulmonary hypertension.
     ERJ Open Res. 2024;10:00085-2024.
     Abstract     Related articles   
     
     
351. VURAN G, Yilmazer MM, Gerceker E, Zihni C, et al
     Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension.
     Cardiol Young. 2024 Mar 6:1-5. doi: 10.1017/S1047951124000362.
     Abstract     Related articles   
     
     
352. LIU H, Zhang YW, Zhang QQ, Wang YX, et al
     [Effects of human umbilical cord mesenchymal stem cells (MSCs)-derived exosomes on pulmonary vascular remodeling in hypoxic pulmonary hypertension].
     Sheng Li Xue Bao. 2024;76:33-44.
     Abstract     Related articles   
     
     
353. MADDALONI C, Ronci S, De Rose DU, Bersani I, et al
     Neonatal persistent pulmonary hypertension related to a novel TBX4 mutation: case report and review of the literature.
     Ital J Pediatr. 2024;50:41.
     Abstract     Related articles   
     
     
354. ITTERMANN T, Kaczmarek S, Obst A, Konemann R, et al
     Metabolic cost of unloading pedalling in different groups of patients with pulmonary hypertension and volunteers.
     Sci Rep. 2024;14:5394.
     Abstract     Related articles   
     
     
355. ANH NTH, Minh Dien T, Thi Ha L, Thao Nguyen P, et al
     Factors in the Neonatal Period Associated With Pulmonary Hypertension at 28 Days of Life in Broncho-Pulmonary Dysplasia.
     Glob Pediatr Health. 2024;11:2333794X241234571.
     Abstract     Related articles   
     
     
356. TENZING D, Suolang P, Gesang D, Suolang D, et al
     Effect of furosemide in the treatment of high-altitude pulmonary edema.
     BMC Pulm Med. 2024;24:109.
     Abstract     Related articles   
     
     
357. MUNTEANU A, Kundnani NR, Caraba A
     Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.
     Eur Rev Med Pharmacol Sci. 2024;28:1314-1326.
     Abstract     Related articles   
     
     
358. CROWLEY AV, Banfield M, Gupta A, Raj R, et al
     Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
     Cureus. 2024;16:e53336.
     Abstract     Related articles   
     
     
359. PENATE GP, Parra NO, Morera JAD, Menaca AM, et al
     Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare digital platform in pulmonary arterial hypertension: a pilot study.
     Front Public Health. 2024;12:1335072.
     Abstract     Related articles   
     
     
360. ZAHID S, Anjali Garg J, Altibi A, Golwala H, et al
     Mitral Transcatheter Edge-to-Edge Repair: Advancing Treatment Options for Degenerative Mitral Regurgitation.
     Interv Cardiol Clin. 2024;13:155-165.
     Abstract     Related articles   
     
     
361. RANGWALA BS, Sohail Rangwala H
     Comment on: Severe pulmonary hypertension in pulmonary alveolar microlithiasis: A comprehensive literature review.
     Curr Probl Cardiol. 2024 Feb 29:102492. doi: 10.1016/j.cpcardiol.2024.102492.
     Abstract     Related articles   
     
     
362. MORA-CUESTA VM, Martinez-Menaca A, Iturbe-Fernandez D, Tello-Mena S, et al
     Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients.
     Heart Lung Circ. 2024 Feb 29:S1443-9506(24)00037.
     Abstract     Related articles   
     
     
363. LI J, Xiong J, Liu P, Peng Y, et al
     Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
     Adv Rheumatol. 2024;64:15.
     Abstract     Related articles   
     
     
364. WHITE RJ, Lachant DJ, Benza RL
     Risk scores as a surrogate in pulmonary arterial hypertension: a different lens.
     Lancet Respir Med. 2024;12:e9-e10.
     Abstract     Related articles   
     
     
365. HARHAY MO, Blette BS, Kawut SM
     Risk scores as a surrogate in pulmonary arterial hypertension: a different lens - Authors' reply.
     Lancet Respir Med. 2024;12:e11.
     Abstract     Related articles   
     
     
366. HODNICK R, Cohen ML, Loehner JB, Mazzanti J, et al
     Continuous Positive Airway Pressure in the Treatment of Pediatric High Altitude Pulmonary Edema: A Case Study.
     Wilderness Environ Med. 2024;35:78-81.
     Abstract     Related articles   
     
     
367. QIAN YL, He JG
     [Current status and progress of research on pediatric pulmonary arterial hypertension].
     Zhonghua Er Ke Za Zhi. 2024;62:278-281.
     Abstract     Related articles   
     
     
368. HIRANO Y, Amano M, Obokata M, Izumo M, et al
     Practice guidance for stress echocardiography.
     J Echocardiogr. 2024;22:1-15.
     Abstract     Related articles   
     
     
369. MATHUR M, Malinowski M, Jazwiec T, Timek TA, et al
     Leaflet remodeling reduces tricuspid valve function in a computational model.
     J Mech Behav Biomed Mater. 2024;152:106453.
     Abstract     Related articles   
     
     
370. SANDEEP B, Cheng H, Yan Y, Huang X, et al
     Right ventricle-pulmonary artery coupling in pulmonary artery hypertension its measurement and pharmacotherapy.
     Curr Probl Cardiol. 2024;49:102425.
     Abstract     Related articles   
     
     
371. SHORT K, McBride M, Anderson S, Miller R, et al
     Survival of Infants With Severe Congenital Kidney Disease After ECMO and Kidney Support Therapy.
     Pediatrics. 2024 Feb 2:e2023062717. doi: 10.1542/peds.2023-062717.
     Abstract     Related articles   
     
     
372. CUETO-ROBLEDO G, Tovar-Benitez D, Alfaro-Cruz A, Gonzalez-Hermosillo LM, et al
     Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment.
     Curr Probl Cardiol. 2024;49:102404.
     Abstract     Related articles   
     
     
373. HAIDER MA, Pearce KJ, Chesler NC, Hill NA, et al
     Application and reduction of a nonlinear hyperelastic wall model capturing ex vivo relationships between fluid pressure, area, and wall thickness in normal and hypertensive murine left pulmonary arteries.
     Int J Numer Method Biomed Eng. 2024;40:e3798.
     Abstract     Related articles   
     
     
374. LI XM, Zhu XJ, Jing ZC
     Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
     Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
     Abstract     Related articles   
     
     
375. LI M, Pan W, Tian D, Chen D, et al
     Diagnostic Value of Serum Galectin-3 Binding Protein Level in Patients with Pulmonary Arterial Hypertension.
     Curr Vasc Pharmacol. 2024;22:67-77.
     Abstract     Related articles   
     
     
376. PEREZ-VIZCAINO F, Barbera JA, Rodriguez Chiaradia DA
     Vitamin D and Pulmonary Arterial Hypertension.
     Arch Bronconeumol. 2024;60:131-132.
     Abstract     Related articles   
     
     
377. HEO J, Kang H
     Platelet-derived growth factor-stimulated pulmonary artery smooth muscle cells regulate pulmonary artery endothelial cell dysfunction through extracellular vesicle miR-409-5p.
     Biol Chem. 2023;405:203-215.
     Abstract     Related articles   
     
     
378. ALY S, Qattea I, Othman H, Nguyen HH, et al
     Outcomes of atrioventricular septal defects with and without down syndrome: analysis of the national inpatient database.
     Cardiol Young. 2024;34:614-623.
     Abstract     Related articles   
     
     
379. MATSUMOTO K, Miyawaki Y, Katsuyama T, Nakadoi T, et al
     Immunosuppressive Treatment for an anti-U(1) Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial Hypertension.
     Intern Med. 2024;63:671-676.
     Abstract     Related articles   
     
     
380. PAVSIC N, Kacar P, Dolenc J, Prokselj K, et al
     One-minute sit-to-stand test in patients with pulmonary arterial hypertension associated with congenital heart disease: A single-center prospective study.
     Hellenic J Cardiol. 2024;75:41-47.
     Abstract     Related articles   
     
     
381. PANAGIOTIDOU E, Betaoutou A, Fouka E, Papakosta D, et al
     Phenotyping exercise limitation of patients with Interstitial Fibrosing Lung Disease: the importance of exercise hemodynamics.
     Pulmonology. 2024;30:104-112.
     Abstract     Related articles   
     
     
382. UNALDI E, Firlatan B, Duzgun SA, Koca SS, et al
     Case report: Pulmonary endarterectomy in Takayasu arteritis patient with group IV pulmonary hypertension: A rare clinical scenario.
     Int J Rheum Dis. 2024;27:e15119.
     Abstract     Related articles   
     
     
383. MONDEN Y, Une D, Mitsumune S, Shimokawahara H, et al
     Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with bronchial obstruction by a carcinoid tumor.
     Pulm Circ. 2024;14:e12354.
     Abstract     Related articles   
     
     
384. WILSON BK, Sadowski CK, Baeten RG
     A clinician's guide to pulmonary hypertension.
     JAAPA. 2024 Mar 14. doi: 10.1097/01.JAA.0001007360.09090.
     Abstract     Related articles   
     
     
385. CHANG AJ, Goh CH
     Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation.
     Tex Heart Inst J. 2024;51:e238209.
     Abstract     Related articles   
     
     
386. GERGES C, Vollmers K, Skoro-Sajer N, Dannenberg V, et al
     Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension.
     Eur J Heart Fail. 2024 Mar 13. doi: 10.1002/ejhf.3187.
     Abstract     Related articles   
     
     
387. BONGIOVANNI G, Tonutti A, Stainer A, Nigro M, et al
     Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review.
     BMJ Open Respir Res. 2024;11:e002161.
     Abstract     Related articles   
     
     
388. KITAGHENDA FK, Hidig SM
     Improvement in Pulmonary Hypertension Following Metabolic and Bariatric Surgery: a Brief Review and Meta-analysis.
     Obes Surg. 2024 Mar 13. doi: 10.1007/s11695-024-07162.
     Abstract     Related articles   
     
     
389. BHAGWAT AP, Sharath HV, Seth NH, Puri SN, et al
     Persistent Pulmonary Hypertension of Newborns Secondary to Labile Hypoxemia Associated With Cyanosis: A Case Series.
     Cureus. 2024;16:e54016.
     Abstract     Related articles   
     
     
390. DIALLO TH, Nana Yeboah F, Djafarou Boubacar R, Faraj R, et al
     Severe pulmonary hypertension associated with hypothyroidism and mixed aortic valve disease: A case report.
     SAGE Open Med Case Rep. 2024;12:2050313X241237405.
     Abstract     Related articles   
     
     
391. HU Z, Fan S
     Progress in the application of echocardiography in neonatal pulmonary hypertension.
     J Matern Fetal Neonatal Med. 2024;37:2320673.
     Abstract     Related articles   
     
     
392. MUNKS J, Yogeswaran A, Antoine TK, Blumrich LA, et al
     A Novel Rat Model of Mild Pulmonary Hypertension Associated with Pulmonary Venous Congestion Induced by Left Pulmonary Vein Banding.
     Int J Mol Sci. 2024;25:2827.
     Abstract     Related articles   
     
     
393. WANG MT, Weng KP, Chang SK, Huang WC, et al
     Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.
     Int J Mol Sci. 2024;25:2734.
     Abstract     Related articles   
     
     
394. RESHMA S J, George S, P SK 5th
     Pulmonary hypertension in newly diagnosed obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome patients attending a tertiary care centre-a cross-sectional analysis.
     Ir J Med Sci. 2024 Mar 12. doi: 10.1007/s11845-024-03657.
     Abstract     Related articles   
     
     
395. MORRISROE K, Hansen D, Stevens W, Ross L, et al
     Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis.
     Rheumatology (Oxford). 2024 Mar 12:keae166. doi: 10.1093.
     Abstract     Related articles   
     
     
396. DE JAGER J, Brouwer F, Reijman J, van der Palen RLF, et al
     Occurrence of hyperoxia during iNO treatment for persistent pulmonary hypertension of the newborn: a cohort study.
     Eur J Pediatr. 2024 Mar 12. doi: 10.1007/s00431-024-05506.
     Abstract     Related articles   
     
     
397. PEREZ-PENATE GM, Julia-Serda G, Galvan-Fernandez H, Aleman-Segura D, et al
     Safety of inhaled nitric oxide withdrawal in severe chronic pulmonary hypertension.
     Pulm Circ. 2024;14:e12344.
     Abstract     Related articles   
     
     
398. ALOTAIBI M, Yang JZ, Papamatheakis DG, McGuire WC, et al
     Cardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease.
     Respir Res. 2024;25:121.
     Abstract     Related articles   
     
     
399. SUNG C, Han S, Yoon S, Han SA, et al
     Diagnostic Performance of Perfusion-Only SPECT/CT for Chronic Thromboembolic Pulmonary Hypertension in Comparison With Ventilation-Perfusion Planar, SPECT, and SPECT/CT Imaging.
     Clin Nucl Med. 2024 Mar 11. doi: 10.1097/RLU.0000000000005142.
     Abstract     Related articles   
     
     
400. HU BZ, Jiang C, Ding YJ, Qin W, et al
     The clinical and hemodynamic characteristics of pulmonary hypertension in patients with OSA-COPD overlap syndrome.
     Am J Med Sci. 2024 Mar 9:S0002-9629(24)01120-0. doi: 10.1016/j.amjms.2024.
     Abstract     Related articles   
     
     
401. JAMOUSSI A, Ben Mrad N, Rachdi E, Jarraya F, et al
     Hemodynamic profile of pulmonary arterial hypertension in a Tunisian center.
     Tunis Med. 2023;101:751-755.
     Abstract     Related articles   
     
     
402. ADACHI T, Adachi S, Nakano Y, Yasuda K, et al
     Detrimental Impact of Comorbid Mental Disorders in Chronic Thromboembolic Pulmonary Hypertension?- A Retrospective Observational Study.
     Circ Rep. 2024;6:80-85.
     Abstract     Related articles   
     
     
403. LONG C, Fan W, Liu Y, Hong K, et al
     Stress hyperglycemia is associated with poor outcome in critically ill patients with pulmonary hypertension.
     Front Endocrinol (Lausanne). 2024;15:1302537.
     Abstract     Related articles   
     
     
404. KHEZERLOUY-AGHDAM N, Toufan Tabrizi M, Seyed Toutounchi K, Jabbaripour Sarmadian A, et al
     Challenging in pulmonary thromboembolism diagnosis in patients with disproportionate pulmonary hypertension and severe mitral stenosis: Report of two cases.
     Clin Case Rep. 2024;12:e8597.
     Abstract     Related articles   
     
     
405. LIU B, Yi D, Xia X, Ramirez K, et al
     General Capillary Endothelial Cells Undergo Reprogramming into Arterial Endothelial Cells in Pulmonary Hypertension through HIF-2alpha/Notch4 Pathway.
     bioRxiv [Preprint]. 2024 Mar 10:2024.02.13.580227.
     Abstract     Related articles   
     
     
406. KUSNER J, Krasuski RA
     Pulmonary Hypertension in Adult Congenital Heart Disease-Related Heart Failure.
     Heart Fail Clin. 2024;20:209-221.
     Abstract     Related articles   
     
     
407. ZHOU S, Zhang Q, Yang H, Zhu Y, et al
     Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH.
     Life Sci. 2024;342:122538.
     Abstract     Related articles   
     
     
408. ZHANG H, Wang X, Liu J, Zhang Y, et al
     Role of neutrophil myeloperoxidase in the development and progression of high-altitude pulmonary edema.
     Biochem Biophys Res Commun. 2024;703:149681.
     Abstract     Related articles   
     
     
409. MANZI G, Mariani MV, Filomena D, Recchioni T, et al
     Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis.
     Vascul Pharmacol. 2024;154:107280.
     Abstract     Related articles   
     
     
410. LIU C, Lv X, Kong X, Meng L, et al
     Ultrasound-mediated HGF Gene Microbubbles Mitigate Hyperkinetic Pulmonary Arterial Hypertension in Rabbits.
     Heart Lung Circ. 2024;33:251-259.
     Abstract     Related articles   
     
     
411. CHI PL, Cheng CC, Wang MT, Liao JB, et al
     Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1alpha and Runx2.
     Cardiovasc Res. 2024;120:203-214.
     Abstract     Related articles   
     
     
412. BRADY S, Krishnan U, Saqi A, Vargas D, et al
     Twins with alveolar capillary dysplasia with misalignment of pulmonary veins: Strategies for diagnosis and management.
     J Neonatal Perinatal Med. 2024;17:147-152.
     Abstract     Related articles   
     
     
413. CORRADO A, Mansueto N, Correale M, Rella V, et al
     Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers.
     Vascul Pharmacol. 2024;154:107252.
     Abstract     Related articles   
     
     
414. DIGNAM JP, Sharma S, Stasinopoulos I, MacLean MR, et al
     Pulmonary arterial hypertension: Sex matters.
     Br J Pharmacol. 2024;181:938-966.
     Abstract     Related articles   
     
     
415. MAMAZHAKYPOV A, Veith C, Schermuly RT, Sydykov A, et al
     Surgical protocol for pulmonary artery banding in mice to generate a model of pressure-overload-induced right ventricular failure.
     STAR Protoc. 2023;4:102660.
     Abstract     Related articles   
     
     
416. POUDEL S, Gautam S, Adhikari P, Zafren K, et al
     Physiological Effects of Sildenafil Versus Placebo at High Altitude: A Systematic Review.
     High Alt Med Biol. 2024;25:16-25.
     Abstract     Related articles   
     
     
417. CHEN CY, Mei-Tzu W, Sung SH, Wu YJ, et al
     Exercise capacity-hemodynamics mismatch in elderly patients with pulmonary hypertension: A nationwide multicenter study from Taiwan Society of Cardiology Pulmonary Hypertension Registry (TAIPANS).
     Heliyon. 2024;10:e27537.
     Abstract     Related articles   
     
     
418. ROMMEL KP, Hobohm L, Rothman AMK, Lurz P, et al
     Radiation to Illuminate the Path of Neuromodulation for Pulmonary Hypertension.
     JACC Basic Transl Sci. 2024;9:257-259.
     Abstract     Related articles   
     
     
419. HORN-OUDSHOORN EJJ, Vermeulen MJ, Knol R, Bout-Rebel R, et al
     Multicentre, randomised controlled trial of physiological-based cord clamping versus immediate cord clamping in infants with a congenital diaphragmatic hernia (PinC): statistical analysis plan.
     Trials. 2024;25:198.
     Abstract     Related articles   
     
     
420. BENZA RL, Grunig E, Sandner P, Stasch JP, et al
     The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
     Eur Respir Rev. 2024;33:230183.
     Abstract     Related articles   
     
     
421. KIM MS, Jeon K, Kim EK, Park TK, et al
     Usefulness of cardiopulmonary exercise test combined with exercise stress echocardiography in mild chronic thromboembolic pulmonary disease.
     Echocardiography. 2024;41:e15795.
     Abstract     Related articles   
     
     
422. VALLADALES-RESTREPO LF, Gaviria-Mendoza A, Machado-Duque ME, Vallejos-Narvaez A, et al
     Prescription patterns of ambrisentan in some cities of Colombia.
     Clin Respir J. 2024;18:e13736.
     Abstract     Related articles   
     
     
423. HEMILA H, de Man AME
     Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports.
     BMC Pulm Med. 2024;24:140.
     Abstract     Related articles   
     
     
424. SMUKOWSKA-GORYNIA A, Iwanczyk S, Rzymski P, Wozniak P, et al
     Situation of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension during the COVID-19 pandemic (2020-2022): clinical outcomes, prognostic factors, and response to vaccination.
     Pol Arch Intern Med. 2024 Mar 19:16706. doi: 10.20452/pamw.16706.
     Abstract     Related articles   
     
     
425. VARIAN F, Dick J, Battersby C, Roman S, et al
     Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.
     Pulm Circ. 2024;14:e12337.
     Abstract     Related articles   
     
     
426. BUDHRAM B, Weatherald J, Humbert M
     Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis.
     Semin Respir Crit Care Med. 2024 Mar 18. doi: 10.1055/s-0044-1782217.
     Abstract     Related articles   
     
     
427. HU X, Sun Y, Wang S, Zhao H, et al
     CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.
     J Am Heart Assoc. 2024;13:e031867.
     Abstract     Related articles   
     
     
428. DUARTE VE
     Women and the Heart: Gender-Related Differences in Cardiovascular Care.
     Methodist Debakey Cardiovasc J. 2024;20:1-3.
     Abstract     Related articles   
     
     
429. PARK E, Safdar Z
     Pulmonary Hypertension in Women.
     Methodist Debakey Cardiovasc J. 2024;20:70-80.
     Abstract     Related articles   
     
     
430. LIU J, Fang G, Lan C, Qiu C, et al
     Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-kappaB Signaling Pathway to Attenuate Vascular Remodeling.
     Drug Des Devel Ther. 2024;18:767-780.
     Abstract     Related articles   
     
     
431. XIA W, Qian Y, Lin Y, Quan R, et al
     Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry.
     Respirology. 2024 Mar 17. doi: 10.1111/resp.14700.
     Abstract     Related articles   
     
     
432. PROVENCHER S, Arsenault BJ, Bonnet S
     Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries.
     J Am Heart Assoc. 2024;13:e033446.
     Abstract     Related articles   
     
     
433. ALHATHLI E, Julian T, Girach ZUA, Thompson AAR, et al
     Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension.
     J Am Heart Assoc. 2024;13:e032256.
     Abstract     Related articles   
     
     
434. GUAN D, Tian L, Li W, Gao H, et al
     Using LDDMM and a kinematic cardiac growth model to quantify growth and remodelling in rat hearts under PAH.
     Comput Biol Med. 2024;171:108218.
     Abstract     Related articles   
     
     
435. TAN JS, Yang Y, Wang J, Wang Y, et al
     Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization study.
     Biosci Trends. 2024;18:94-104.
     Abstract     Related articles   
     
     
436. ZHANG C, Xi Y, Zhang Y, He P, et al
     Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study.
     Heart Lung. 2024;64:189-197.
     Abstract     Related articles   
     
     
437. GAWLITZA J, Endres S, Fries P, Graf M, et al
     Machine learning assisted feature identification and prediction of hemodynamic endpoints using computed tomography in patients with CTEPH.
     Int J Cardiovasc Imaging. 2024;40:569-577.
     Abstract     Related articles   
     
     
438. SCHIFFRIN EL, Pollock DM
     Endothelin System in Hypertension and Chronic Kidney Disease.
     Hypertension. 2023 Dec 7. doi: 10.1161/HYPERTENSIONAHA.123.21716.
     Abstract     Related articles   
     
     
439. ZHOU R, Zhao Z, Liu J, Liu M, et al
     Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis.
     Heart Lung. 2024;64:36-45.
     Abstract     Related articles   
     
     
440. DWIVEDI K, Sharkey M, Alabed S, Langlotz CP, et al
     External validation, radiological evaluation, and development of deep learning automatic lung segmentation in contrast-enhanced chest CT.
     Eur Radiol. 2024;34:2727-2737.
     Abstract     Related articles   
     
     
441. MEIFANG W, Ying W, Wen C, Kaizu X, et al
     Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials.
     Heart Fail Rev. 2024;29:305-320.
     Abstract     Related articles   
     
     
442. INTERNATIONAL BR
     Retracted: Curcumin Improves Pulmonary Hypertension Rats by Regulating Mitochondrial Function.
     Biomed Res Int. 2024;2024:9769323.
     Abstract     Related articles   
     
     
443. MENG X, Du L, Xu S, Zhou L, et al
     Periodontitis exacerbates pulmonary hypertension by promoting IFNgamma(+) T cell infiltration in mice.
     Int J Oral Sci. 2024;16:27.
     Abstract     Related articles   
     
     
444. GHOFRANI HA, Simonneau G, D'Armini AM, Fedullo P, et al
     Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
     Lancet Respir Med. 2024;12:e21-e30.
     Abstract     Related articles   
     
     
445. MA RZ, Jin CL, Yang S, Han PP, et al
     Evaluating the efficacy of balloon pulmonary angioplasty using quantitative analysis of SPECT pulmonary ventilation/perfusion scintigraphy in patients with chronic thromboembolic pulmonary hypertension.
     Quant Imaging Med Surg. 2024;14:2590-2602.
     Abstract     Related articles   
     
     
446. NORTON CE
     Role of Sensory Nerves in Pulmonary Fibrosis.
     Int J Mol Sci. 2024;25:3538.
     Abstract     Related articles   
     
     
447. SYKORA M, Szeiffova Bacova B, Andelova K, Egan Benova T, et al
     Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.
     Int J Mol Sci. 2024;25:3275.
     Abstract     Related articles   
     
     
448. VAIDYA A, Vaidy A, Al-Otaibi M, Zlotshewer B, et al
     Pelvic Vein Obstruction in Chronic Thromboembolic Pulmonary Hypertension: A Novel Association.
     J Clin Med. 2024;13:1553.
     Abstract     Related articles   
     
     
449. LECKA-AMBROZIAK A, Kot K
     Pulmonary Hypertension and Hypothyroidism-Still an Important Clinical Coincidence in Paediatric Population, an Endocrinologist's Point of View.
     Life (Basel). 2024;14:302.
     Abstract     Related articles   
     
     
450. IVANAUSKIENE T, Cesna S, Grigoniene E, Gumbiene L, et al
     Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Insights from a Pilot Low-Volume Centre Study and a Comparative Analysis with Other Centres.
     Medicina (Kaunas). 2024;60:461.
     Abstract     Related articles   
     
     
451. MOISII P, Jari I, Naum AG, Butcovan D, et al
     Takayasu's Arteritis: A Special Case Report and Review of the Literature.
     Medicina (Kaunas). 2024;60:456.
     Abstract     Related articles   
     
     
452. NAGAI Y, Murayama M, Kaga S, Shima H, et al
     Echocardiographic estimation of right ventricular diastolic stiffness based on pulmonary regurgitant velocity waveform analysis in precapillary pulmonary hypertension.
     Int J Cardiovasc Imaging. 2024 Mar 27. doi: 10.1007/s10554-024-03083.
     Abstract     Related articles   
     
     
453. GARCIA-LUNAR I, Jorge I, Saiz J, Solanes N, et al
     Metabolic changes contribute to maladaptive right ventricular hypertrophy in pulmonary hypertension beyond pressure overload: an integrative imaging and omics investigation.
     Basic Res Cardiol. 2024 Mar 27. doi: 10.1007/s00395-024-01041.
     Abstract     Related articles   
     
     
454. SCHANZ O, Criner GJ, Rali P, Gayen S, et al
     Pulmonary Vasodilator Therapy Is Associated with Decreased Mortality in Patients with Chronic Lung Disease and Severe Pulmonary Hypertension.
     J Cardiovasc Dev Dis. 2024;11:89.
     Abstract     Related articles   
     
     
455. KULARATNE M, Gerges C, Jevnikar M, Humbert M, et al
     Updated Clinical Classification and Hemodynamic Definitions of Pulmonary Hypertension and Its Clinical Implications.
     J Cardiovasc Dev Dis. 2024;11:78.
     Abstract     Related articles   
     
     
456. USMANI SUR, Hasan SU, Ali SH, Ahmed SH, et al
     Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis.
     Asian J Surg. 2024 Mar 25:S1015-9584(24)00430.
     Abstract     Related articles   
     
     
457. YU H, Lee D, Chae Y, Choi M, et al
     Myxomatous mitral valve disease and associated pulmonary hypertension might increase serum angiopoietin-2 in dogs.
     Am J Vet Res. 2024 Mar 30:1-9. doi: 10.2460/ajvr.23.12.0289.
     Abstract     Related articles   
     
     
458. WANG C, Zhu Q, Tan D, Walline J, et al
     Acute High-Output Heart Failure with Pulmonary Hypertension and Severe Liver Injury Caused by Amlodipine Poisoning: A Case Report.
     Cardiovasc Toxicol. 2024 Mar 26. doi: 10.1007/s12012-024-09849.
     Abstract     Related articles   
     
     
459. ZHAO H, Song J, Li X, Xia Z, et al
     The role of immune cells and inflammation in pulmonary hypertension: mechanisms and implications.
     Front Immunol. 2024;15:1374506.
     Abstract     Related articles   
     
     
460. MAI H, Yang X, Xie Y, Zhou J, et al
     Identification of the shared hub gene signatures and molecular mechanisms between HIV-1 and pulmonary arterial hypertension.
     Sci Rep. 2024;14:7048.
     Abstract     Related articles   
     
     
461. WANG LY, Wang BJ, Gao XY
     [Research progress on auxiliary indexes and methods of diagnosis and treatment of patent ductus arteriosus in preterm].
     Zhonghua Er Ke Za Zhi. 2024;62:381-384.
     Abstract     Related articles   
     
     
462. DENG X, Luo H, He J, Deng W, et al
     Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKalpha signaling.
     Clin Exp Hypertens. 2024;46:2332695.
     Abstract     Related articles   
     
     
463. KELLIHAN HB, Cutchin E, Sirochman A, Gasper D, et al
     Severe Pulmonary Hypertension and Pulmonary Thrombi in a Dog.
     CASE (Phila). 2023;8.
     Abstract     Related articles   
     
     
464. WAHADNEH OA, Alitter Q, Raju A, Alziadin N, et al
     Prevalence and Impact of Pulmonary Hypertension on Acute Decompensated Heart Failure with Preserved Ejection Fraction Hospitalizations: A Five-Year Retrospective Analysis.
     Curr Probl Cardiol. 2024 Mar 22:102537. doi: 10.1016/j.cpcardiol.2024.102537.
     Abstract     Related articles   
     
     
465. WU J, Ling Y
     A review regarding the article 'Impact of tricuspid regurgitation severity on mortality in pulmonary hypertension patients: A comprehensive analysis.
     Curr Probl Cardiol. 2024;49:102535.
     Abstract     Related articles   
     
     
466. KRZYZEWSKA A, Baranowska-Kuczko M, Galicka A, Kasacka I, et al
     Cannabidiol may prevent the development of congestive hepatopathy secondary to right ventricular hypertrophy associated with pulmonary hypertension in rats.
     Pharmacol Rep. 2024 Mar 22. doi: 10.1007/s43440-024-00579.
     Abstract     Related articles   
     
     
467. STUBBS HD, Cannon J, Knightbridge E, Durrington C, et al
     Sendaway capillary NT-proBNP in pulmonary hypertension.
     BMJ Open Respir Res. 2024;11:e002124.
     Abstract     Related articles   
     
     
468. WEATHERALD J, Nathan SD, El-Kersh K, Argula RG, et al
     Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study.
     BMJ Open Respir Res. 2024;11:e002116.
     Abstract     Related articles   
     
     
469. HNATJUK MS, Konovalenko SO, Kritsak MY, Gargula TI, et al
     Morphometric aspects of remodeling of the arterial bed of the testicles in post- resection portal and pulmonary hypertensions.
     Pol Merkur Lekarski. 2024;52:67-72.
     Abstract     Related articles   
     
     
470. VILLAS BOAS HJ, Paschoal IA, Pereira MC
     Impulse oscillometry in patients with pulmonary arterial hypertension: an exploratory study.
     Clinics (Sao Paulo). 2024;79:100313.
     Abstract     Related articles   
     
     
471. YAN X, Huang J, Zeng Y, Zhong X, et al
     CGRP attenuates pulmonary vascular remodeling by inhibiting the cGAS-STING-NFkappaB pathway in pulmonary arterial hypertension.
     Biochem Pharmacol. 2024;222:116093.
     Abstract     Related articles   
     
     
472. HOLT MF, Flo A, Ravnestad H, Bjorno V, et al
     Invasive haemodynamics at rest and exercise in cardiac amyloidosis.
     ESC Heart Fail. 2024;11:1263-1268.
     Abstract     Related articles   
     
     
473. SUBRAMANIAN P, Singhal M, Sharma A
     Unique segmental branching of right pulmonary artery in association with patent ductus arteriosus and anomalous carotid origin of left vertebral artery.
     Pediatr Pulmonol. 2024;59:1092-1094.
     Abstract     Related articles   
     
     
474. YANG T, Li X, Luo Q, Zhao Q, et al
     Angiographic classification of total occlusion and its implication on balloon pulmonary angioplasty.
     ESC Heart Fail. 2024;11:795-804.
     Abstract     Related articles   
     
     
475. XUEYUAN L, Yanping X, Jiaoqiong G, Yuehui Y, et al
     Autonomic nervous modulation: early treatment for pulmonary artery hypertension.
     ESC Heart Fail. 2024;11:619-627.
     Abstract     Related articles   
     
     
476. RASHIDI F, Bilehjani E, Mousavi-Aghdas SA, Parvizi R, et al
     Massive primary pulmonary artery rhabomyosarcoma: A case report.
     Rom J Intern Med. 2024;62:67-74.
     Abstract     Related articles   
     
     
477. LI X, Song L, Lu Z, Tong S, et al
     Integrative analyses of whole-transcriptome sequencing reveals CeRNA regulatory network in pulmonary hypertension treated with FGF21.
     Int Immunopharmacol. 2024;132:111925.
     Abstract     Related articles   
     
     
478. ZHANG P, Da Silva Goncalves Bos D, Vang A, Feord J, et al
     Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension.
     Pulm Circ. 2024;14:e12358.
     Abstract     Related articles   
     
     
479. KONG D, Liu J, Lu J, Zeng C, et al
     HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
     Arterioscler Thromb Vasc Biol. 2024 Apr 4. doi: 10.1161/ATVBAHA.123.319916.
     Abstract     Related articles   
     
     
480. NASSAR GM, Jameson R, Sathiyaraj S, Bidikian N, et al
     Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy.
     Clin Kidney J. 2024;17:sfae047.
     Abstract     Related articles   
     
     
481. XING Y, Hou Y, Fan T, Gao R, et al
     Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension.
     Acta Pharm Sin B. 2024;14:1726-1741.
     Abstract     Related articles   
     
     
482. OKI T, Nagatani Y, Ishida S, Hashimoto M, et al
     Right main pulmonary artery distensibility on dynamic ventilation CT and its association with respiratory function.
     Eur Radiol Exp. 2024;8:50.
     Abstract     Related articles   
     
     
483. GEGENAVA M, Gegenava T
     Association of pulmonary hypertension with outcomes in patients with Systemic sclerosis and other connective tissue disorders: review and meta-analysis.
     Sarcoidosis Vasc Diffuse Lung Dis. 2024;41:e2024023.
     Abstract     Related articles   
     
     
484. PRICE LC, Kouranos V, Baughman R, Bloom C, et al
     Use of pulmonary arterial hypertension therapies in patient swith sarcoidosis-associated pulmonary hypertension.
     Sarcoidosis Vasc Diffuse Lung Dis. 2024;41:e2024024.
     Abstract     Related articles   
     
     
485. JAEGER P, Toskas I, Henes JK, Shcherbyna S, et al
     Impact of pulmonary hypertension on outcomes after TEER in patients suffering from mitral regurgitation.
     Clin Res Cardiol. 2024 Apr 2. doi: 10.1007/s00392-024-02442.
     Abstract     Related articles   
     
     
486. TANG M, Luo J, Liu Q, Song J, et al
     Coexistence of pulmonary arterial hypertension and straight back syndrome in a patient with a novel BMPR2 variant affecting cytoplasmic tail domain.
     Eur J Med Res. 2024;29:209.
     Abstract     Related articles   
     
     
487. HU X, Lv X, Zhang L, Li SS, et al
     Noncoding RNA Lipotherapeutics: A Promising Breakthrough in Pulmonary Hypertension Treatment.
     Curr Pharm Biotechnol. 2024 Mar 29. doi: 10.2174/0113892010302590240321073509.
     Abstract     Related articles   
     
     
488. VAN KALSBEEK D, Anani AR, El-Kersh K
     Pulmonary artery vasodilators for treatment of pulmonary hypertension complicating fibrosing mediastinitis.
     Respir Med Case Rep. 2024;49:102006.
     Abstract     Related articles   
     
     
489. KHEMCHANDANI M, Nasir K, Qureshi R, Dhrolia M, et al
     Frequency of Pulmonary Hypertension and Its Associated Risk Factors in End-Stage Renal Disease (ESRD) Patients on Maintenance Hemodialysis.
     Cureus. 2024;16:e55206.
     Abstract     Related articles   
     
     
490. KOZAILY E, Akdogan ER, Dorsey NS, Tedford RJ, et al
     Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
     Curr Hypertens Rep. 2024 Apr 1. doi: 10.1007/s11906-024-01296.
     Abstract     Related articles   
     
     
491. WANG S, Li H, Liu Q, Ma H, et al
     Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats.
     Int Heart J. 2024;65:318-328.
     Abstract     Related articles   
     
     
492. ZUO Y, Li B, Gao M, Xiong R, et al
     Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension.
     Respir Res. 2024;25:147.
     Abstract     Related articles   
     
     
493. CRITSER PJ, Buchmiller TL, Gauvreau K, Zalieckas JM, et al
     Exercise-induced Pulmonary Hypertension in Long-term Survivors of Congenital Diaphragmatic Hernia.
     J Pediatr. 2024 Mar 27:114034. doi: 10.1016/j.jpeds.2024.114034.
     Abstract     Related articles   
     
     
494. THE EDITORS OF THE LANCET RESP
     Retraction and republication-Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
     Lancet Respir Med. 2024;12:262-263.
     Abstract     Related articles   
     
     
495. WANG J, Liu C, Huang SS, Wang HF, et al
     Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.
     Eur J Pharmacol. 2024;970:176492.
     Abstract     Related articles   
     
     
496. CHEN Y, Liu J, Zhang Q, Chai L, et al
     Activation of CaMKII/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2.
     Eur J Pharmacol. 2024;970:176483.
     Abstract     Related articles   
     
     
497. MARTINEZ-MENACA A, Mora-Cuesta VM, Iturbe-Fernandez D, Sainz-Ezquerra Belmonte B, et al
     Quality of Life and the Cardiopulmonary Exercise Test in Pulmonary Arterial Hypertension Patients.
     Arch Bronconeumol. 2024;60:253-255.
     Abstract     Related articles   
     
     
498. DISTLER O, Ofner C, Huscher D, Jordan S, et al
     Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
     Rheumatology (Oxford). 2024;63:1139-1146.
     Abstract     Related articles   
     
     
499. TODOROKI Y, Satoh M, Kubo S, Kosaka S, et al
     Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
     Rheumatology (Oxford). 2024;63:1068-1075.
     Abstract     Related articles   
     
     
500. YOUSSEF M, Boutros Salama M, Rehman N, Hanna C, et al
     Pulmonary hypertension survival and hospitalisations in people living with HIV: a systematic review and meta-analysis.
     BMJ Open Respir Res. 2024;11:e002318.
     Abstract     Related articles   
     
     
501. ALBULUSHI A, Al-Asmi S, Al-Abri M, Al-Farhan H, et al
     The Road to Heart Transplant in a Patient With Cardiomyopathy, Shone Complex, and Severe Pulmonary Hypertension.
     JACC Case Rep. 2024;29:102323.
     Abstract     Related articles   
     
     
502. PAPAGEORGIOU ST, Damdoumis S, Goulis D, Tzikas S, et al
     The Effect of Pulmonary Hypertension on Mortality and Intensive Care Unit Admission in Patients With SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
     Heart Lung Circ. 2024 Apr 9:S1443-9506(24)00076.
     Abstract     Related articles   
     
     
503. MORALES-CANO D, Barreira B, Callejo M, Olivencia MA, et al
     Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human.
     Vascul Pharmacol. 2024 Apr 8:107371. doi: 10.1016/j.vph.2024.107371.
     Abstract     Related articles   
     
     
504. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
     Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study.
     Front Vet Sci. 2024;11:1327453.
     Abstract     Related articles   
     
     
505. KISKADDON A, Dang T, Mauriello D
     Tadalafil in Neonates and Infants With Pulmonary Hypertension Secondary to Bronchopulmonary Dysplasia.
     J Pediatr Pharmacol Ther. 2024;29:140-143.
     Abstract     Related articles   
     
     
506. WANG T, Zhou D, Chen Y, Kuang S, et al
     Non-invasive estimation of pulmonary hypertension and clinical deterioration risk in pediatric congenital heart disease: Development and validation of predictive tools.
     Chin Med J (Engl). 2024 Apr 8. doi: 10.1097/CM9.0000000000003070.
     Abstract     Related articles   
     
     
507. KOUDSTAAL T, van den Bosch T, Bergen I, Lila K, et al
     Predominance of M2 macrophages in organized thrombi in chronic thromboembolic pulmonary hypertension patients.
     Eur J Immunol. 2024 Apr 9:e2350670. doi: 10.1002/eji.202350670.
     Abstract     Related articles   
     
     
508. CHAUDHARI T, Schmidt Sotomayor N, Maheshwari R
     Diagnosis, management and long term cardiovascular outcomes of phenotypic profiles in pulmonary hypertension associated with congenital diaphragmatic hernia.
     Front Pediatr. 2024;12:1356157.
     Abstract     Related articles   
     
     
509. WEI X, Zou Y, Dong S, Chen Y, et al
     Recombinant hirudin attenuates pulmonary hypertension and thrombosis in acute pulmonary embolism rat model.
     PeerJ. 2024;12:e17039.
     Abstract     Related articles   
     
     
510. UGWENDUM D, Mbome Y, Arrey Agbor DB, Burkhanova U, et al
     Methylphenidate-Induced Non-ischemic Heart Failure With Reduced Ejection Fraction and Mild Pulmonary Hypertension.
     Cureus. 2024;16:e55604.
     Abstract     Related articles   
     
     
511. PASIANA AD, Idrus HH, Purnamasari I
     Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-kappaB Signaling Pathway to Attenuate Vascular Remodeling [LETTER].
     Drug Des Devel Ther. 2024;18:1023-1024.
     Abstract     Related articles   
     
     
512. SHI TY, Wen XH, Meng J, Lu YW, et al
     Effect of IL-17 on pulmonary artery smooth muscle cells and connective tissue disease-associated pulmonary arterial hypertension.
     Immun Inflamm Dis. 2024;12:e1243.
     Abstract     Related articles   
     
     
513. CHAI Y, Gu X, Zhang H, Xu X, et al
     Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress.
     Aging (Albany NY). 2024;16:5027-5037.
     Abstract     Related articles   
     
     
514. LAU E, Kotlyar E, Makanji Y, Yu DY, et al
     Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study.
     J Med Econ. 2024;27:596-604.
     Abstract     Related articles   
     
     
515. STEGER M, Canuet M, Enache I, Goetsch T, et al
     Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
     Respir Med. 2024;225:107585.
     Abstract     Related articles   
     
     
516. NJOKU F, Pugh N, Brambilla D, Kroner B, et al
     Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry.
     Am J Hematol. 2024;99:900-909.
     Abstract     Related articles   
     
     
517. CHALIA M, Seager E, Rao A, Hannam S, et al
     Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment.
     Acta Paediatr. 2024 Feb 8. doi: 10.1111/apa.17142.
     Abstract     Related articles   
     
     
518. MURPHY SP, Deferm S, Yucel E, Urbut SM, et al
     Right Ventricular - Pulmonary Arterial Coupling and All-Cause Mortality in Patients with Mitral Annular Calcification Related Mitral Valve Dysfunction.
     J Am Soc Echocardiogr. 2024 Jan 20:S0894-7317(24)00011.
     Abstract     Related articles   
     
     
519. YE P, Deng Y, Gu Y, Liu P, et al
     GRK2-YAP signaling is implicated in pulmonary arterial hypertension development.
     Chin Med J (Engl). 2024;137:846-858.
     Abstract     Related articles   
     
     
520. MEGIED MAAE, Abouelhassan MA, Hadwa ESAES
     Prognostic and diagnostic utility of interleukin-6 in pediatric pulmonary arterial hypertension - a case-control study.
     Eur J Pediatr. 2024;183:1637-1643.
     Abstract     Related articles   
     
     
521. BESSA-GONCALVES M, Braganca B, Martins-Dias E, Vinhas A, et al
     Blockage of the adenosine A(2B) receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension.
     Purinergic Signal. 2024;20:163-179.
     Abstract     Related articles   
     
     
522. SANCHEZ-HOLGADO M, Bravo MC, Alvarez-Garcia P, Lopez-Ortego P, et al
     Severe pulmonary hypertension and circulatory failure associated with Congenital syphilis. Case report.
     J Neonatal Perinatal Med. 2024 Apr 13. doi: 10.3233/NPM-230133.
     Abstract     Related articles   
     
     
523. ZHOU Z, Gu Y, Tian L, Zheng H, et al
     Development and Validation of a Nomogram of Persistent Pulmonary Hypertension in Adult Pretricuspid Shunts After Correction.
     J Am Heart Assoc. 2024 Apr 19:e032412. doi: 10.1161/JAHA.123.032412.
     Abstract     Related articles   
     
     
524. AMERI P, Mercurio V, Pollesello P, Anker MS, et al
     A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.
     Eur J Heart Fail. 2024 Apr 19. doi: 10.1002/ejhf.3236.
     Abstract     Related articles   
     
     
525. YANG L, Peng Z, Gong F, Yan W, et al
     TRPC4 Aggravates Hypoxic Pulmonary Hypertension by Promoting Pulmonary Endothelial Cell Apoptosis.
     Free Radic Biol Med. 2024 Apr 16:S0891-5849(24)00403.
     Abstract     Related articles   
     
     
526. MURAYAMA M, Sugimori H, Yoshimura T, Kaga S, et al
     Deep learning to assess right ventricular ejection fraction from two-dimensional echocardiograms in precapillary pulmonary hypertension.
     Echocardiography. 2024;41:e15812.
     Abstract     Related articles   
     
     
527. LI X, Tan JS, Xu J, Zhao Z, et al
     Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study.
     BMC Pulm Med. 2024;24:185.
     Abstract     Related articles   
     
     
528. BHATTACHARYA S
     Emergencies in Pulmonary Hypertension.
     Cardiol Clin. 2024;42:273-278.
     Abstract     Related articles   
     
     
529. LUO T, Wu H, Zhu W, Zhang L, et al
     Emerging therapies: Potential roles of SGLT2 inhibitors in the management of pulmonary hypertension.
     Respir Med. 2024 Apr 15:107631. doi: 10.1016/j.rmed.2024.107631.
     Abstract     Related articles   
     
     
530. SHIM YD, Chen MC, Ha S, Chang HJ, et al
     Multi-scaled temporal modeling of cardiovascular disease progression: An illustration of proximal arteries in pulmonary hypertension.
     J Biomech. 2024;168:112059.
     Abstract     Related articles   
     
     
531. KHAN SL, Danoff SK, Kulkarni T, Reichuber J, et al
     Practice Patterns for Screening and Treating Interstitial Lung Disease-related Pulmonary Hypertension at Specialty Care Centers in the United States.
     Ann Am Thorac Soc. 2024 Apr 16. doi: 10.1513/AnnalsATS.202402.
     Abstract     Related articles   
     
     
532. MA Y, Guo D, Wang J, Gong J, et al
     Effects of right ventricular remodeling in chronic thromboembolic pulmonary hypertension on the outcomes of balloon pulmonary angioplasty: a 2D-speckle tracking echocardiography study.
     Respir Res. 2024;25:164.
     Abstract     Related articles   
     
     
533. ADRIAN RJ, Alerhand S, Liteplo A, Shokoohi H, et al
     Is pulmonary hypertension protective against cardiac tamponade? A systematic review.
     Intern Emerg Med. 2024 Apr 15. doi: 10.1007/s11739-024-03566.
     Abstract     Related articles   
     
     
534. ZHOU R, Li R, Ding Q, Zhang Y, et al
     OPN silencing reduces hypoxic pulmonary hypertension via PI3K-AKT-induced protective autophagy.
     Sci Rep. 2024;14:8670.
     Abstract     Related articles   
     
     
535. KIM C, Kim S, Kim H, Hwang J, et al
     Long-term impact of late pulmonary hypertension requiring medication in extremely preterm infants with severe bronchopulmonary dysplasia.
     Sci Rep. 2024;14:8705.
     Abstract     Related articles   
     
     
536. BOYLE TA, Ha B, Haq I, Killu A, et al
     Atrial Fibrillation Ablation in Patients with Pulmonary Hypertension: Multicenter Experience.
     Heart Rhythm. 2024 Apr 13:S1547-5271(24)02383.
     Abstract     Related articles   
     
     
537. MORELL E, Colglazier E, Becerra J, Stevens L, et al
     A single institution anesthetic experience with catheterization of pediatric pulmonary hypertension patients.
     Pulm Circ. 2024;14:e12360.
     Abstract     Related articles   
     
     
538. PU Y, Li G, Zhang T, Cui Y, et al
     Intravascular ultrasound imaging of pulmonary artery with high-altitude pulmonary hypertension.
     Quant Imaging Med Surg. 2024;14:3204-3209.
     Abstract     Related articles   
     
     
539. LABYK A, Krakowian M, Mysiorski L, Lichodziejewska B, et al
     Refined balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension - reference center experience.
     Postepy Kardiol Interwencyjnej. 2024;20:84-88.
     Abstract     Related articles   
     
     
540. GAO YH, Zhu YN, Bai JW, Liang S, et al
     Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
     Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
     Abstract     Related articles   
     
     
541. WANG L, Liu J, Zhou L, Fu Q, et al
     Serum PM20D1 levels in patients with idiopathic pulmonary arterial hypertension and its clinical significance.
     BMC Cardiovasc Disord. 2024;24:207.
     Abstract     Related articles   
     
     
542. GOHIR Q, Ghosh S, Bosher O, Crawford E, et al
     Pleural-based giant solitary fibrous tumour with associated hypoglycaemia: unusual presentation with pulmonary hypertension in a patient with Doege-Potter syndrome.
     Clin Med (Lond). 2023;23:518-520.
     Abstract     Related articles   
     
     
543. VIRSINSKAITE R, Karia N, Kotecha T, Schreiber BE, et al
     Pulmonary hypertension - the latest updates for physicians.
     Clin Med (Lond). 2023;23:449-454.
     Abstract     Related articles   
     
     
544. SCHULZE KM, Horn AG, Muller-Delp JM, White ZJ, et al
     Pulmonary hypertension impairs vasomotor function in rat diaphragm arterioles.
     Microvasc Res. 2024 Apr 11:104686. doi: 10.1016/j.mvr.2024.104686.
     Abstract     Related articles   
     
     
545. KLEIN F, Dinesh S, Fiedler D, Grun K, et al
     Identification of Serum Interleukin-22 as Novel Biomarker in Pulmonary Hypertension: A Translational Study.
     Int J Mol Sci. 2024;25:3985.
     Abstract     Related articles   
     
     
546. ISRAEL-BIET D, Pastre J, Nunes H
     Sarcoidosis-Associated Pulmonary Hypertension.
     J Clin Med. 2024;13:2054.
     Abstract     Related articles   
     
     
547. KLETZER J, Scharinger B, Demirel O, Kaufmann R, et al
     Radiological Parameters for the Detection of Pulmonary Hypertension in Severe Aortic Valve Stenosis and Their Influence on Mortality: Does Sex Matter?
     J Clin Med. 2024;13:1999.
     Abstract     Related articles   
     
     
548. TATSUOKA Y, Carr ZJ, Jayakumar S, Lin HM, et al
     Pulmonary Hypertension and the Risk of 30-Day Postoperative Pulmonary Complications after Gastrointestinal Surgical or Endoscopic Procedures: A Retrospective Propensity Score-Weighted Cohort Analysis.
     J Clin Med. 2024;13:1996.
     Abstract     Related articles   
     
     
549. ANAND S, Cronin EM
     Arrhythmias in Patients with Pulmonary Hypertension and Right Ventricular Failure: Importance of Rhythm Control Strategies.
     J Clin Med. 2024;13:1866.
     Abstract     Related articles   
     
     
550. BRAUNLICH J, Seyfarth HJ, Wirtz H
     Effect of Nasal High Flow (NHF) on Right Heart Function in Stable Patients with Pulmonary Hypertension of Different WHO Classes.
     J Clin Med. 2024;13:1862.
     Abstract     Related articles   
     
     
551. ARAVAMUDHAN A, Dieffenbach PB, Choi KM, Link PA, et al
     Non-canonical IKB kinases regulate YAP/TAZ and pathological vascular remodeling behaviors in pulmonary artery smooth muscle cells.
     Physiol Rep. 2024;12:e15999.
     Abstract     Related articles   
     
     
552. KUMAR A, Raj S, Singh S, Ghotra GS, et al
     Empowering Little Fighters: Post-Cardiotomy Pediatric ECMO and the Journey to Recovery.
     Ann Card Anaesth. 2024;27:128-135.
     Abstract     Related articles   
     
     
553. ALI AF, Miyasaka R, Jellis CL
     It's All About That Right Ventricle.
     J Am Heart Assoc. 2024;13:e034711.
     Abstract     Related articles   
     
     
554. JOSE A, Rahman N, Opotowsky AR, Glorioso TJ, et al
     Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study.
     J Am Heart Assoc. 2024;13:e033847.
     Abstract     Related articles   
     
     
555. ZHOU X, Liang B, Lin W, Zha L, et al
     Identification of MACC1 as a potential biomarker for pulmonary arterial hypertension based on bioinformatics and machine learning.
     Comput Biol Med. 2024;173:108372.
     Abstract     Related articles   
     
     
556. ALMUTAIRI M, Hefnawy A, Almotairy A, Alobaida A, et al
     Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part ?).
     Int J Pharm. 2024;655:124044.
     Abstract     Related articles   
     
     
557. ORNOWSKA S, Wudarski M, Dziewiecka E, Olesinska M, et al
     Naifold capillaroscopy in mixed connective tissue disease patients.
     Clin Rheumatol. 2024;43:1703-1709.
     Abstract     Related articles   
     
     
558. CARRARO CC, Turck P, Bahr A, Donatti L, et al
     Effect of free and nanoemulsified beta-caryophyllene on monocrotaline-induced pulmonary arterial hypertension.
     Biochim Biophys Acta Mol Cell Res. 2024;1871:119704.
     Abstract     Related articles   
     
     
559. CAMARDA ND, Ibarrola J, Biwer LA, Jaffe IZ, et al
     Mineralocorticoid Receptors in Vascular Smooth Muscle: Blood Pressure and Beyond.
     Hypertension. 2024;81:1008-1020.
     Abstract     Related articles   
     
     
560. HAKGOR A, Dursun A, Kahraman BC, Yazar A, et al
     Prognostic impact of main pulmonary artery to ascending aorta diameter ratio in patients with severe aortic stenosis underwent transcatheter aortic valve implantation.
     Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31000.
     Abstract     Related articles   
     
     
561. LIO KU, Bashir R, Lakhter V, Li S, et al
     Impact of reperfusion therapies on clot resolution and long-term outcomes in patients with pulmonary embolism.
     J Vasc Surg Venous Lymphat Disord. 2024 Feb 16:101823.
     Abstract     Related articles   
     
     
562. AL TABOSH T, Liu H, Koca D, Al Tarrass M, et al
     Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
     Angiogenesis. 2024;27:211-227.
     Abstract     Related articles   
     
     
563. LIU H, Zhang Q, Liu C, Zhang Y, et al
     Human umbilical cord mesenchymal stromal cell-derived exosomes alleviate hypoxia-induced pulmonary arterial hypertension in mice via macrophages.
     Stem Cells. 2023 Dec 28:sxad098. doi: 10.1093.
     Abstract     Related articles   
     
     
564. BRENNER R, Drescher T, Locher R, Bilz S, et al
     Pulmonary and systemic hemodynamics in patients with hyperthyroidism.
     Am J Med. 2023 Dec 15:S0002-9343(23)00760-X. doi: 10.1016/j.amjmed.2023.
     Abstract     Related articles   
     
     
565. SURUGA K, Shimokawahara H, Miyagi A, Sugiyama Y, et al
     Flow Grade-Based Success Rates, Complication Rates, and Balloon Pulmonary Angioplasty Patency for Total Occlusions.
     Can J Cardiol. 2024;40:625-633.
     Abstract     Related articles   
     
     
566. HE Y, Li Q, Zhang C, Keller BB, et al
     Treprostinil Effectiveness in Higher-Risk Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension.
     Can J Cardiol. 2024;40:613-621.
     Abstract     Related articles   
     
     
567. CORONA LFV, Reyna TSR
     Right Ventricle and Autoimmune Diseases.
     Curr Rheumatol Rev. 2024;20:127-132.
     Abstract     Related articles   
     
     
568. KUBOTA K, Miyanaga S, Akao M, Mitsuyoshi K, et al
     Association of delayed diagnosis of pulmonary arterial hypertension with its prognosis.
     J Cardiol. 2024;83:365-370.
     Abstract     Related articles   
     
     
569. DEBOER EM, Wolter-Warmerdam K, Deterding RR, Marmolejo J, et al
     Cardiopulmonary Phenotypes and Protein Signatures in Children With Down Syndrome.
     Clin Pediatr (Phila). 2024;63:474-481.
     Abstract     Related articles   
     
     
570. NAGUIB M, Aljwaid A, Marella D, Flores RJ, et al
     Nitroprusside Combined with Leg Raise at the Time of Right Heart Catheterization to Differentiate Precapillary from Other Hemodynamic Forms of Pulmonary Hypertension: A Single-Center Pilot Study.
     J Cardiovasc Dev Dis. 2024;11:124.
     Abstract     Related articles   
     
     
571. ZHANG C, Du Q, Zhou X, Qu T, et al
     Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension.
     Respir Res. 2024;25:181.
     Abstract     Related articles   
     
     
572. SUN H, Du Z, Zhang X, Gao S, et al
     Neutrophil extracellular traps promote proliferation of pulmonary smooth muscle cells mediated by CCDC25 in pulmonary arterial hypertension.
     Respir Res. 2024;25:183.
     Abstract     Related articles   
     
     
573. HORIKAWA R, Suzuki R, Yuchi Y, Satomi S, et al
     Pulmonary thrombotic pulmonary hypertension managed using antithrombotic and pulmonary vasodilator treatment.
     J Vet Intern Med. 2024 Apr 25. doi: 10.1111/jvim.17089.
     Abstract     Related articles   
     
     
574. PENG W, Zhang ZY, Xiao YB
     [Research progress on bioinformatics in pulmonary arterial hypertension].
     Zhongguo Dang Dai Er Ke Za Zhi. 2024;26:425-431.
     Abstract     Related articles   
     
     
575. ABDULFATTAH A, John S
     Navigating Diagnostic Challenges: Severe Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease vs. Pulmonary Embolism.
     Cureus. 2024;16:e56907.
     Abstract     Related articles   
     
     
576. FORTMEIER V, Korber MI, Rommel KP, Stolz L, et al
     New Diagnostic Criteria for Pulmonary Hypertension: Impact on Survival Prognostication Following Transcatheter Tricuspid Valve Intervention.
     JACC Cardiovasc Interv. 2024;17:1073-1075.
     Abstract     Related articles   
     
     
577. WANG B, Xu Y, Huang Y, Shao S, et al
     miR-210-5p Promotes Pulmonary Hypertension by Blocking ATP2A2.
     Cardiovasc Drugs Ther. 2024 Apr 24. doi: 10.1007/s10557-024-07568.
     Abstract     Related articles   
     
     
578. SOARES LL, Leite LB, Freitas MO, Ervilha LOG, et al
     Effect of experimental pulmonary arterial hypertension on renal and bone parameters of rats submitted to resistance exercise training.
     An Acad Bras Cienc. 2024;96:e20230446.
     Abstract     Related articles   
     
     
579. XU J, Sun X, Cao Y, Zhu H, et al
     Fractional exhaled nitric oxide in idiopathic pulmonary arterial hypertension and mixed connective tissue disease complicating pulmonary hypertension.
     BMC Pulm Med. 2024;24:199.
     Abstract     Related articles   
     
     
580. HOU Q, Jiang J, Na K, Zhang X, et al
     Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation study.
     Sci Rep. 2024;14:9294.
     Abstract     Related articles   
     
     
581. ALBULUSHI A, Al-Riyami MB, Al-Rawahi N, Al-Mukhaini M, et al
     Effectiveness of Mechanical Circulatory Support Devices in Reversing Pulmonary Hypertension Among Heart Transplant Candidates: A Systematic Review.
     Curr Probl Cardiol. 2024 Apr 21:102579. doi: 10.1016/j.cpcardiol.2024.102579.
     Abstract     Related articles   
     
     
582. SADDOUK FZ, Kuzemczak AP, Saito J, Greif DM, et al
     Endothelial HIFalpha-PDGF-B to smooth muscle Beclin1 signaling sustains pathological muscularization in pulmonary hypertension.
     JCI Insight. 2024 Apr 23:e162449. doi: 10.1172/jci.insight.162449.
     Abstract     Related articles   
     
     
583. PENUMATSA KC, Sharma Y, Warburton RR, Singhal A, et al
     Lung-specific interleukin 6 mediated transglutaminase 2 activation and cardiopulmonary fibrogenesis.
     Front Immunol. 2024;15:1371706.
     Abstract     Related articles   
     
     
584. JIN J, Hao W, Xie D
     Meta-analysis of the correlation between pulmonary hypertension and echocardiographic parameters in patients with chronic kidney disease.
     PeerJ. 2024;12:e17245.
     Abstract     Related articles   
     
     
585. CHEN Y, Zhang S, Lu X, Xie W, et al
     Unusual cause of muscle weakness, type II respiratory failure and pulmonary hypertension: a case report of ryanodine receptor type 1(RYR1)-related myopathy.
     BMC Pulm Med. 2024;24:194.
     Abstract     Related articles   
     
     
586. LENKA J, Foley R, Metersky M, Salmon A, et al
     Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future.
     Expert Rev Respir Med. 2024 Apr 24:1-13. doi: 10.1080/17476348.2024.2345684.
     Abstract     Related articles   
     
     
587. GOPAGONDANAHALLI KR, Abdul Haium AA, Vora SJ, Sundararaghavan S, et al
     Serial tissue Doppler imaging in the evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension among extremely preterm infants: a prospective observational study.
     Front Pediatr. 2024;12:1349175.
     Abstract     Related articles   
     
     
588. QIU LL, Li Y, Pei LJ, Ma GT, et al
     [Successful rescue of postpartum pulmonary hypertension crisis: a multidisciplinary approach in a case report].
     Zhonghua Xin Xue Guan Bing Za Zhi. 2024;52:420-424.
     Abstract     Related articles   
     
     
589. SMOLICH JJ, Kenna KR, Mynard JP
     Extended period of ventilation before delayed cord clamping augments left-to-right shunting and decreases systemic perfusion at birth in preterm lambs.
     J Physiol. 2024;602:1791-1813.
     Abstract     Related articles   
     
     
590. NOVARA ME, Di Martino E, Stephens B, Nayrouz M, et al
     Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications.
     Drugs R D. 2024;24:13-28.
     Abstract     Related articles   
     
     
591. ERDOGAN M, Esatoglu SN, Kilickiran Avci B, Hatemi G, et al
     Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis.
     Intern Emerg Med. 2024;19:731-743.
     Abstract     Related articles   
     
     
592. IVY D, Beghetti M, Juaneda-Simian E, Ravindranath R, et al
     Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study.
     Eur J Pediatr. 2024;183:2141-2153.
     Abstract     Related articles   
     
     
593. HUNG JH, Langlois S, Wiebe M, Wild B, et al
     Increased Elastase and Matrix Metalloproteinase Levels in the Pulmonary Arteries of Infants With Congenital Diaphragmatic Hernia.
     J Pediatr Surg. 2024 Feb 1:S0022-3468(24)00060.
     Abstract     Related articles   
     
     
594. PERURENA-PRIETO J, Callejas-Moraga EL, Sanz-Martinez MT, Colobran R, et al
     Prognostic value of anti-IFI16 autoantibodies in pulmonary arterial hypertension and mortality in patients with systemic sclerosis.
     Med Clin (Barc). 2024;162:370-377.
     Abstract     Related articles   
     
     
595. APPADURAI V, Kinno M, Minga I, Slostad B, et al
     The value of ultrasound enhancing agents in the echocardiographic acquisition of pulmonary artery systolic pressure: An invasive to non-invasive correlation study.
     Int J Cardiovasc Imaging. 2024;40:821-830.
     Abstract     Related articles   
     
     
596. DISTLER O, Bonderman D, Coghlan JG, Denton CP, et al
     Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines.
     Arthritis Rheumatol. 2024;76:777-782.
     Abstract     Related articles   
     
     
597. PULIGANDLA P, Skarsgard E, Baird R, Guadagno E, et al
     Diagnosis and management of congenital diaphragmatic hernia: a 2023 update from the Canadian Congenital Diaphragmatic Hernia Collaborative.
     Arch Dis Child Fetal Neonatal Ed. 2024;109:239-252.
     Abstract     Related articles   
     
     
598. GOL D, Vyas A, Visana N, Patel A, et al
     Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertension.
     Ann Pharm Fr. 2024;82:464-472.
     Abstract     Related articles   
     
     
599. GOKHALE T, Harinstein ME
     Challenging the Paradigm of Post-Capillary Pulmonary Hypertension.
     Am J Cardiol. 2023 Dec 30:S0002-9149(23)01445.
     Abstract     Related articles   
     
     
600. PATARROYO APONTE MM
     When Bad and Worse Collide: Venous Thromboembolic Disease and Pulmonary Hypertension.
     Am J Cardiol. 2024 Jan 9:S0002-9149(23)00252.
     Abstract     Related articles   
     
     
601. CELESKI M, Segreti A, Polito D, Valente D, et al
     Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation.
     Am J Cardiol. 2024;217:102-118.
     Abstract     Related articles   
     
     
602. MALIGIREDDY A, Jabri A, Zghouzi M, Rojulpote C, et al
     Maternal and Fetal Outcomes in Pulmonary Hypertension During Pregnancy: A Contemporary Nationwide Analysis.
     Am J Cardiol. 2024 Apr 23:S0002-9149(24)00277.
     Abstract     Related articles   
     
     
603. HANSEN TS, Karimi Galougahi K, Tang O, Tsang M, et al
     The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodelling via redox and inflammatory mechanisms.
     Am J Physiol Heart Circ Physiol. 2023 Dec 22. doi: 10.1152/ajpheart.00090.2023.
     Abstract     Related articles   
     
     
604. ARADHYULA V, Vyas R, Dube P, Haller ST, et al
     Novel Insights into the Pathobiology of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction.
     Am J Physiol Heart Circ Physiol. 2024 Apr 19. doi: 10.1152/ajpheart.00068.2024.
     Abstract     Related articles   
     
     
605. PHILIP N, Yun X, Pi H, Murray S, et al
     Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2024;326:L252-L265.
     Abstract     Related articles   
     
     
606. HATABAH D, De Marco T, McGlothlin DP, Malloy M, et al
     Low global arginine bioavailability: a common phenomenon in pulmonary hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2024;326:L514-L515.
     Abstract     Related articles   
     
     
607. ALI M, Choudhary R, Singh K, Kumari S, et al
     Hypobaric hypoxia modulated structural characteristics of circulating cell-free DNA in high-altitude pulmonary edema.
     Am J Physiol Lung Cell Mol Physiol. 2024;326:L496-L507.
     Abstract     Related articles   
     
     
608. GUTOR SS, Salinas RI, Nichols DS, Bazzano JMR, et al
     Repetitive sulfur dioxide exposure in mice models post-deployment respiratory syndrome.
     Am J Physiol Lung Cell Mol Physiol. 2024;326:L539-L550.
     Abstract     Related articles   
     
     
609. RAJAGOPAL S, Yu YR
     Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2024;209:131-133.
     Abstract     Related articles   
     
     
610. FERRIAN S, Cao A, McCaffrey EF, Saito T, et al
     Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.
     Am J Respir Crit Care Med. 2024;209:206-218.
     Abstract     Related articles   
     
     
611. NAEIJE R, Tonelli AR
     Pulmonary Artery Wedge Pressure in the Diagnosis of Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2024;209:242-244.
     Abstract     Related articles   
     
     
612. HARDER EM, Divo MJ, Washko GR, Leopold JA, et al
     Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.
     Am J Respir Crit Care Med. 2024;209:316-324.
     Abstract     Related articles   
     
     
613. KUDRYASHOVA TV, Jiang L, Goncharova EA
     What Is All of the Hype About? Hypusine Signaling as a Driver of Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2024 Feb 27. doi: 10.1164/rccm.202401-0195.
     Abstract     Related articles   
     
     
614. LILEY J, Newnham M, Bleda M, Bunclark K, et al
     Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.
     Am J Respir Crit Care Med. 2024 Mar 12. doi: 10.1164/rccm.202307-1236.
     Abstract     Related articles   
     
     
615. HARDER E, Abtin F, Nardelli P, Brownstein A, et al
     Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning.
     Am J Respir Crit Care Med. 2024 Mar 19. doi: 10.1164/rccm.202312-2343.
     Abstract     Related articles   
     
     
616. JAIN A, Epelbaum O
     Synchronous Pulmonary Arterial and Pulmonary Venous Thrombosis in Pancreatic Cancer.
     Am J Respir Crit Care Med. 2024;209:751-752.
     Abstract     Related articles   
     
     
617. BJORKMAN KR, Miles KG, Bellew LE, Schneider KA, et al
     Patent Ductus Arteriosus and Lung MRI Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2024 Apr 3. doi: 10.1164/rccm.202310-1733.
     Abstract     Related articles   
     
     
618. HAKIM A, Fricker ZP, Feuerstein JD, Farber HW, et al
     Recurrent Gastrointestinal Bleeding in a Patient With Pulmonary Arterial Hypertension Treated With Sotatercept.
     Ann Intern Med. 2024;177:115-117.
     Abstract     Related articles   
     
     
619. MADANI MM
     Acute Kidney Injury Post Pulmonary Thromboendarterectomy: Is It a Valid Concern? A Word of Caution.
     Ann Thorac Surg. 2024;117:318-319.
     Abstract     Related articles   
     
     
620. FRANTZ RP, Swift AJ
     Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.
     Chest. 2024;165:12-13.
     Abstract     Related articles   
     
     
621. CELANT LR, Wessels JN, Marcus JT, Meijboom LJ, et al
     Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
     Chest. 2024;165:181-191.
     Abstract     Related articles   
     
     
622. BALASUBRAMANIAN A, Larive B, Horn EM, DuBrock HM, et al
     Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.
     Chest. 2024 Feb 12:S0012-3692(24)00155-7. doi: 10.1016/j.chest.2024.
     Abstract     Related articles   
     
     
623. FAUVEL C, White RJ, Vanderpool RR, Badagliacca R, et al
     Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
     Chest. 2024;165:431-436.
     Abstract     Related articles   
     
     
624. MOORE J, Remy J, Altschul E, Chusid J, et al
     Thoracic Applications of Spectral CT Scan.
     Chest. 2024;165:417-430.
     Abstract     Related articles   
     
     
625. O'MEARA K, Stone G, Buch E, Brownstein A, et al
     Atrial Arrhythmias in Patients with Pulmonary Hypertension.
     Chest. 2024 Mar 5:S0012-3692(24)00291-5. doi: 10.1016/j.chest.2024.
     Abstract     Related articles   
     
     
626. PROVENCHER S, Mai V, Bonnet S
     Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities.
     Chest. 2024;165:682-691.
     Abstract     Related articles   
     
     
627. OROZCO-LEVI M, de Jesus Perez V
     Precision Solutions: A Strategy to Improve Medical Care for Patients With Pulmonary Hypertension in Latin America.
     Chest. 2024;165:669-672.
     Abstract     Related articles   
     
     
628. SAHAY S
     Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No.
     Chest. 2024;165:494-496.
     Abstract     Related articles   
     
     
629. WEATHERALD J, Sitbon O
     POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
     Chest. 2024;165:492-494.
     Abstract     Related articles   
     
     
630. YOGESWARAN A, Gall H, Funderich M, Wilkins MR, et al
     Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis.
     Chest. 2024 Mar 18:S0012-3692(24)00309-X. doi: 10.1016/j.chest.2024.
     Abstract     Related articles   
     
     
631. AL-NAAMANI N, Thenappan T
     Left Heart Disease Phenotype in Pulmonary Arterial Hypertension: Considerations for Therapy.
     Chest. 2024;165:766-768.
     Abstract     Related articles   
     
     
632. KEARNEY K, Brown K, Celermajer DS, Collins N, et al
     Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
     Chest. 2024;165:967-977.
     Abstract     Related articles   
     
     
633. MURUGESAN P, Zhang Y, Huang Y, Chengong Zong N, et al
     Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.
     Circ Res. 2024 Feb 1. doi: 10.1161/CIRCRESAHA.123.323090.
     Abstract     Related articles   
     
     
634. COSTE B, Delmas P
     PIEZO Ion Channels in Cardiovascular Functions and Diseases.
     Circ Res. 2024;134:572-591.
     Abstract     Related articles   
     
     
635. CHU X, Kheirollahi V, Lingampally A, Chelladurai P, et al
     GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension.
     Circ Res. 2024 Apr 19. doi: 10.1161/CIRCRESAHA.123.323736.
     Abstract     Related articles   
     
     
636. BIAN JS, Chen J, Zhang J, Tan J, et al
     ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
     Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
     Abstract     Related articles   
     
     
637. LUO Y, Qi X, Zhang Z, Zhang J, et al
     Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
     Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
     Abstract     Related articles   
     
     
638. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
     Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
     Abstract     Related articles   
     
     
639. SHEN H, Gao Y, Ge D, Tan M, et al
     BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
     Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430.
     Abstract     Related articles   
     
     
640. RAO RJ, Chan SY
     Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
     Circulation. 2024;149:1372-1374.
     Abstract     Related articles   
     
     
641. NASROLLAHIZADEH A, Soleimani H, Nasrollahizadeh A, Hashemi SM, et al
     Navigating the Sotatercept landscape: A meta-analysis of clinical outcomes.
     Clin Cardiol. 2024;47:e24173.
     Abstract     Related articles   
     
     
642. HU X, Yuan P, Chen J, Wang S, et al
     Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.
     Clin Cardiol. 2024;47:e24245.
     Abstract     Related articles   
     
     
643. FEI Q, Pan J, Zhang F, Lin Y, et al
     Comparison of Different Treatments of Persistent Pulmonary Hypertension of the Newborn: A Systematic Review and Network Meta-Analysis.
     Crit Care Med. 2024 Feb 16. doi: 10.1097/CCM.0000000000006227.
     Abstract     Related articles   
     
     
644. DATE N, Nakajima D, Ikeda M, Nishikawa S, et al
     Effect of epoprostenol-induced thrombocytopaenia on lung transplantation for pulmonary arterial hypertension.
     Eur J Cardiothorac Surg. 2024 Mar 27:ezae108. doi: 10.1093.
     Abstract     Related articles   
     
     
645. TAMURA Y, Tamura Y, Shigeta A, Hosokawa K, et al
     Adult-onset idiopathic peripheral pulmonary artery stenosis.
     Eur Respir J. 2023;62:2300763.
     Abstract     Related articles   
     
     
646. HAFNER F, Kindt A, Strobl K, Forster K, et al
     MRI pulmonary artery flow detects lung vascular pathology in preterms with lung disease.
     Eur Respir J. 2023 Sep 7:2202445. doi: 10.1183/13993003.02445-2022.
     Abstract     Related articles   
     
     
647. PLUNKETT MJ, Sayegh ALC, McWilliams TJ, Sithamparanathan S, et al
     The skeletal muscle metaboreflex: a novel driver of ventilation, dyspnoea and pulmonary haemodynamics during exercise in pulmonary arterial hypertension.
     Eur Respir J. 2024;63:2300952.
     Abstract     Related articles   
     
     
648. DURRINGTON C, Hurdman JA, Elliot CA, Maclean R, et al
     Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.
     Eur Respir J. 2024 Feb 1:2300846. doi: 10.1183/13993003.00846-2023.
     Abstract     Related articles   
     
     
649. GERGES C, Montani D, Humbert M, Lang IM, et al
     Hemodynamic phenotypes of pulmonary hypertension associated with left heart disease: a moving target.
     Eur Respir J. 2024 Feb 15:2302280. doi: 10.1183/13993003.02280-2023.
     Abstract     Related articles   
     
     
650. MULLER J, Titz A, Schneider SR, Bauer M, et al
     The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled cross-over trial.
     Eur Respir J. 2024 Feb 29:2301001. doi: 10.1183/13993003.01001-2023.
     Abstract     Related articles   
     
     
651. NAEIJE R
     High altitude travelling with pulmonary arterial hypertension.
     Eur Respir J. 2024;63:2400111.
     Abstract     Related articles   
     
     
652. HOWARD LS, Price LC
     Systematic pulmonary embolism follow-up: why we should all do it!
     Eur Respir J. 2024;63:2400253.
     Abstract     Related articles   
     
     
653. AGARWAL S, Fineman J, Cornfield DN, Alvira CM, et al
     VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS.
     Eur Respir J. 2024 Apr 4:2301518. doi: 10.1183/13993003.01518-2023.
     Abstract     Related articles   
     
     
654. GRYNBLAT J, Bogaard HJ, Eyries M, Meyrignac O, et al
     Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study.
     Eur Respir J. 2024;63:2301634.
     Abstract     Related articles   
     
     
655. WOOLF B, Perry JA, Hong CC, Wilkins MR, et al
     Multi-biobank summary data Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension.
     Eur Respir J. 2024;63:2302031.
     Abstract     Related articles   
     
     
656. SANGES S, Tian W, Dubucquoi S, Chang JL, et al
     B-cells in pulmonary arterial hypertension: friend, foe or bystander?
     Eur Respir J. 2024;63:2301949.
     Abstract     Related articles   
     
     
657. HIRATA Y, Tsuji T, Kotoku J, Sata M, et al
     Echocardiographic artificial intelligence for pulmonary hypertension classification.
     Heart. 2024 Jan 30:heartjnl-2023-323320. doi: 10.1136/heartjnl-2023-323320.
     Abstract     Related articles   
     
     
658. CRISAN S, Baghina RM, Luca SA, Cozlac AR, et al
     Comprehensive imaging in patients with suspected pulmonary arterial hypertension.
     Heart. 2023 Jul 18:heartjnl-2022-322182. doi: 10.1136/heartjnl-2022-322182.
     Abstract     Related articles   
     
     
659. SINGH N, Mehta S
     Artificial intelligence to improve the diagnosis of pulmonary hypertension: promises and pitfalls.
     Heart. 2024 Feb 15:heartjnl-2023-323693. doi: 10.1136/heartjnl-2023-323693.
     Abstract     Related articles   
     
     
660. LUNA-LOPEZ R, Segura de la Cal T, Sarnago Cebada F, Martin de Miguel I, et al
     Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
     Heart. 2024;110:346-352.
     Abstract     Related articles   
     
     
661. D'ALTO M, Bassareo PP
     Raising the bar: triple therapy for pulmonary arterial hypertension associated with congenital heart disease.
     Heart. 2024;110:309-310.
     Abstract     Related articles   
     
     
662. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
     Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
     Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
     Abstract     Related articles   
     
     
663. KOSMIDIS D, Arvanitaki A, Farmakis IT, Liakos A, et al
     Pulmonary vasodilators and exercise in Fontan circulation: a systematic review and meta-analysis.
     Heart. 2024;110:552-559.
     Abstract     Related articles   
     
     
664. WESSELS JN, Bogaard HJ
     Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension: Possible Benefits for Selected Patients.
     J Am Coll Cardiol. 2024;83:485-487.
     Abstract     Related articles   
     
     
665. GRUNIG E, Jansa P, Fan F, Hauser JA, et al
     Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension.
     J Am Coll Cardiol. 2024;83:473-484.
     Abstract     Related articles   
     
     
666. LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al
     Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
     J Am Coll Cardiol. 2023;82:1989-2005.
     Abstract     Related articles   
     
     
667. LOWERY MM, Hill NS, Wang L, Mehra R, et al
     Reply: Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
     J Am Coll Cardiol. 2024;83:e109.
     Abstract     Related articles   
     
     
668. HUANG Z, Duan A, Luo Q, Liu Z, et al
     Probing Sleep-Related Hypoxia's Impact on RV Dysfunction and PAH Survival: Uncertainties Clarified?
     J Am Coll Cardiol. 2024;83:e107.
     Abstract     Related articles   
     
     
669. BEKHUIS Y, Verwerft J, Claessen G
     Exercise Echocardiography for mPAP/CO Slope Estimation: A New Standard for Routine Clinical Care?
     J Am Coll Cardiol. 2024;83:e141-e142.
     Abstract     Related articles   
     
     
670. BRUCE MR, Frasco PE, Sell-Dottin KA, Cuevas CV, et al
     Days Alive and Out of the Hospital After Heart Transplantation: A Retrospective Cohort Study.
     J Cardiothorac Vasc Anesth. 2024;38:93-100.
     Abstract     Related articles   
     
     
671. JHA AK, Rajkumar S, Parida S
     Pulmonary Vascular Resistance-Pulmonary Artery Compliance Relationship and Time Constant in Pulmonary Hypertension Due to Valvular Heart Disease.
     J Cardiothorac Vasc Anesth. 2024 Feb 1:S1053-0770(24)00091.
     Abstract     Related articles   
     
     
672. YENIDOGANAY R, Rancati V, Yerly P, Lu H, et al
     Atrial Flow Regulator: Should We Be Afraid of It?
     J Cardiothorac Vasc Anesth. 2024;38:1284-1286.
     Abstract     Related articles   
     
     
673. ATEFIPOUR N, Dianat M, Badavi M, Radan M, et al
     The Role of Rosmarinic Acid in the Protection against Inflammatory Factors in Rats Model with Monocrotaline-Induced Pulmonary Hypertension: Investigating the Signaling Pathway of NFkappaB, OPG, Runx2, and P-selectin in Heart.
     J Cardiovasc Pharmacol. 2023 Dec 26. doi: 10.1097/FJC.0000000000001534.
     Abstract     Related articles   
     
     
674. LI J, He X, Liu F, Zheng X, et al
     Tumor Necrosis Factor-alpha-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
     J Cardiovasc Pharmacol. 2024;83:73-85.
     Abstract     Related articles   
     
     
675. CONZATTI A, Colombo R, Siqueira R, Campos-Carraro C, et al
     Sulforaphane improves redox homeostasis and right ventricular contractility in a model of pulmonary hypertension.
     J Cardiovasc Pharmacol. 2024 Mar 14. doi: 10.1097/FJC.0000000000001557.
     Abstract     Related articles   
     
     
676. KUMARI K, Vishwakarma VK, Kumar K, Mridha AR, et al
     Effect of benidipine alone and in combination with bosentan and sildenafil in amelioration of pulmonary arterial hypertension in experimental model in rats.
     J Cardiovasc Pharmacol. 2024 Jan 17. doi: 10.1097/FJC.0000000000001541.
     Abstract     Related articles   
     
     
677. JANOWSKI AM, Ravellette KS, Insel M, Garcia JG, et al
     Advanced Hemodynamic and Cluster Analysis for Identifying Novel RV function subphenotypes in Patients with Pulmonary Hypertension.
     J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02178.
     Abstract     Related articles   
     
     
678. CRUZ-UTRILLA A, Lopez-Gude MJ, Velazquez M, Ynsaurriaga FA, et al
     Comment on the article titled "Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension" published by J. Chan et al.
     J Heart Lung Transplant. 2023 Dec 21:S1053-2498(23)02177.
     Abstract     Related articles   
     
     
679. PARIKH R, Farber HW
     Response to "Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD" by Nathan et al.
     J Heart Lung Transplant. 2023 Dec 27:S1053-2498(23)02199.
     Abstract     Related articles   
     
     
680. GHIO S, Corsico A, Rapagnani A, Borrelli E, et al
     Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
     J Heart Lung Transplant. 2024 Jan 4:S1053-2498(23)02203.
     Abstract     Related articles   
     
     
681. MCLAUGHLIN V, Farber HW, Highland KB, Hemnes AR, et al
     Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry).
     J Heart Lung Transplant. 2024;43:272-283.
     Abstract     Related articles   
     
     
682. CHIA AXF, Valchanov K, Ng C, Tsui S, et al
     Perioperative extracorporeal membrane oxygenation support for pulmonary endarterectomy: A 17-year experience from the UK national cohort.
     J Heart Lung Transplant. 2024;43:241-250.
     Abstract     Related articles   
     
     
683. DESJARDIN JT, Kime N, Kolaitis NA, Kronmal RA, et al
     Investigating the "sex paradox" in pulmonary arterial hypertension: results from the Pulmonary Hypertension Association Registry (PHAR).
     J Heart Lung Transplant. 2024 Feb 13:S1053-2498(24)00044.
     Abstract     Related articles   
     
     
684. ZEDER K, Marsh LM, Avian A, Brcic L, et al
     Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
     J Heart Lung Transplant. 2024 Feb 19:S1053-2498(24)01087.
     Abstract     Related articles   
     
     
685. RAKO ZA, Yogeswaran A, Yildiz S, Weidemann P, et al
     Liver stiffness is associated with right heart dysfunction, cardiohepatic syndrome, and prognosis in pulmonary hypertension.
     J Heart Lung Transplant. 2024 Feb 17:S1053-2498(24)00056.
     Abstract     Related articles   
     
     
686. BUNCLARK K, Toshner M
     Anthropometrics are important to consider in purported sex differences in CTEPH outcomes.
     J Heart Lung Transplant. 2024;43:688.
     Abstract     Related articles   
     
     
687. BARBERA JA, Peinado VI, Blanco I
     UNTANGLING SEVERE PULMONARY HYPERTENSION IN COPD.
     J Heart Lung Transplant. 2024 Mar 22:S1053-2498(24)01538.
     Abstract     Related articles   
     
     
688. WATABE K, Goda A, Tobita K, Yokoyama S, et al
     Determinants of physical quality of life in patients with chronic thromboembolic pulmonary hypertension after treatment: Insights from invasive exercise stress test.
     J Heart Lung Transplant. 2024 Apr 16:S1053-2498(24)01562.
     Abstract     Related articles   
     
     
689. HICKS TD, Cameron J, Wang S, Ashrafi A, et al
     Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension.
     J Perinatol. 2024 Feb 5. doi: 10.1038/s41372-024-01881.
     Abstract     Related articles   
     
     
690. MORONTA SC, Bischoff AR, Ryckman KK, Dagle JM, et al
     Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.
     J Perinatol. 2024 Jan 31. doi: 10.1038/s41372-024-01883.
     Abstract     Related articles   
     
     
691. CERVERA SB, Saeed S, Luu TM, Gorgos A, et al
     Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants.
     J Perinatol. 2024 Jan 26. doi: 10.1038/s41372-024-01877.
     Abstract     Related articles   
     
     
692. HAYASHI H, Ning Y, Kurlansky P, Vaynrub A, et al
     Characteristics and prognostic significance of right heart remodeling and tricuspid regurgitation after pulmonary endarterectomy.
     J Thorac Cardiovasc Surg. 2022 Apr 8. pii: S0022-5223(22)00391.
     Abstract     Related articles   
     
     
693. ALNSASRA H, Perue RK, Khalil F, Regev O, et al
     Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS.
     J Thorac Cardiovasc Surg. 2024 Mar 5:S0022-5223(24)00188.
     Abstract     Related articles   
     
     
694. BOUCHET C, Guibert C, Freund-Michel V
     [Nerve growth factor (NGF) in pulmonary hypertension (PH)].
     Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00137-2. doi: 10.1016/j.rmr.2024.
     Abstract     Related articles   
     
     
695. PICCARI L, Wort SJ
     Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?
     Thorax. 2024 Feb 2:thorax-2023-221167. doi: 10.1136/thorax-2023-221167.
     Abstract     Related articles   
     
     
696. NATHAN SD, Johri S, Joly JM, King CS, et al
     Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.
     Thorax. 2024;79:301-306.
     Abstract     Related articles   
     
     
697. GONG S, Li H, Wang L
     Pulmonary artery-pulmonary artery collaterals in chronic thromboembolic pulmonary hypertension.
     Thorax. 2024 Apr 10:thorax-2023-221219. doi: 10.1136/thorax-2023-221219.
     Abstract     Related articles   
     
     
698. CASSADY SJ, Maron BA
     Mildly elevated pulmonary vascular resistance and worsened survival in PH-ILD: an opportunity for earlier diagnosis and intervention?
     Thorax. 2024;79:387-388.
     Abstract     Related articles   
     
     
699. SATO T, Furukawa T, Teramachi R, Fukihara J, et al
     Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
     Thorax. 2024;79:422-429.
     Abstract     Related articles   
     
     
700. STACEL T, Kegler K, Medrala A, Sybila P, et al
     Lung Transplantation in Patients With Pulmonary Hypertension With Extracorporeal Membrane Oxygenation (ECMO) Support: 5-Year Experience.
     Transplant Proc. 2024 Apr 4:S0041-1345(24)00170.
     Abstract     Related articles   
     
     
701. PAWLAK S, Sliwka J, Kwiatkowska J, Wierzyk A, et al
     Pediatric Heart Transplantation in the Context of Severe Pulmonary Hypertension Secondary to Restrictive Cardiomyopathy-Case Report.
     Transplant Proc. 2024 Apr 19:S0041-1345(24)00194.
     Abstract     Related articles   
     
     
702. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
     Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
     PLoS One. 2024;19:e0296068.
     Abstract     Related articles   
     
     
703. LIU H, Pan Z, Wu X, Gong C, et al
     Jagged 2 inhibition attenuates hypoxia-induced mitochondrial damage and pulmonary hypertension through Sirtuin 1 signaling.
     PLoS One. 2024;19:e0297525.
     Abstract     Related articles   
     
     
704. ZHAN S, Wang L, Wang W, Li R, et al
     Analysis of genes characterizing chronic thrombosis and associated pathways in chronic thromboembolic pulmonary hypertension.
     PLoS One. 2024;19:e0299912.
     Abstract     Related articles   
     
     
705. YONEDA K, Seki T, Kawazoe Y, Ohe K, et al
     Immediate postnatal prediction of death or bronchopulmonary dysplasia among very preterm and very low birth weight infants based on gradient boosting decision trees algorithm: A nationwide database study in Japan.
     PLoS One. 2024;19:e0300817.
     Abstract     Related articles   
     
     
706. MATSUNAGA T, Kono A, Nishio M, Yoshii T, et al
     Development and web deployment of prediction model for pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension using machine learning.
     PLoS One. 2024;19:e0300716.
     Abstract     Related articles   
     
     
707. ISHIBASHI T, Inagaki T, Okazawa M, Yamagishi A, et al
     IL-6/gp130 signaling in CD4(+) T cells drives the pathogenesis of pulmonary hypertension.
     Proc Natl Acad Sci U S A. 2024;121:e2315123121.
     Abstract     Related articles